rfhg_142452.1

Basic information about the TSS

---

TSS ID: rfhg_142452.1 Species: human Chr: chr11		Start: 102111130 End: 102111136 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2489633,EH38E1564857)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000629586.2:-281 ENST00000531439.5:-281 AB567720:-281 AB567721:-281 AY316529:-281 GeneID: 10413 HGNC/MGI_ID: HGNC:16262 UniProt_ID: A0A024R3E4 P46937 Nearer transcript ids and distances: AB528588:-284 KJ898207:-284 view more...

Gene_name: Yes1 associated transcriptional regulator Gene_symbol: YAP1 Gene_synonyms: YAP-1 YAP65 Gene_source: HGNC:16262

TATA-Box annotation

---

Distance to TSS:	672
Nearest PromoterID:	NM_001282099
Entrez ID:	10413
Nearest Unigene:	Hs.503692
Nearest Refseq:	NM_006106
Nearest Ensembl:	ENSG00000137693
Gene Name:	Yes1 associated transcriptional regulator
Gene Alias:	COB1|YAP|YAP2|YAP65|YKI
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.428571
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@YAP1 p2@YAP1 p3@YAP1 p4@YAP1 p5@YAP1 p6@YAP1 p7@YAP1 p8@YAP1 p9@YAP1 p10@YAP1
Sample		p1@YAP1	p2@YAP1	p3@YAP1	p4@YAP1	p5@YAP1	p6@YAP1	p7@YAP1	p8@YAP1	p9@YAP1	p10@YAP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	13.83	5.26	6.43	2.92	1.95	0.78	1.17	0.58	0.00	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	13.56	2.83	6.68	4.05	2.63	1.21	1.42	1.42	1.21	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	16.20	3.47	4.24	2.12	0.77	0.19	0.58	2.31	0.58	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	8.32	3.95	4.78	1.46	1.87	0.42	1.04	1.66	0.83	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	12.60	3.15	6.30	2.92	2.70	0.45	0.45	2.02	0.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	10.85	4.85	5.23	3.49	1.36	1.36	1.55	1.16	0.58	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	13.29	2.18	4.58	3.27	0.65	0.44	0.65	3.05	0.22	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.45	5.09	6.78	2.18	1.21	0.73	0.48	1.94	0.48	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	11.11	5.34	6.63	3.42	2.56	0.43	0.85	2.56	0.85	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.07	3.48	4.06	2.32	3.48	1.74	1.74	1.16	2.32	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.51	2.43	5.26	3.23	2.02	0.81	2.02	3.64	0.00	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	2.03	7.72	2.03	2.85	0.00	1.22	4.07	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	18.70	12.73	9.35	1.13	3.39	0.16	1.77	0.81	0.32	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.94	11.28	6.01	1.35	2.86	1.20	0.75	0.60	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.91	9.44	9.44	1.32	4.17	0.22	0.22	0.66	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	14.08	5.53	6.79	1.51	2.26	0.25	0.50	0.50	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.10	10.92	6.55	0.44	1.75	0.66	0.44	1.31	0.66	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	11.81	10.97	10.12	1.69	1.27	1.27	1.27	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	14.40	12.26	5.86	1.07	1.60	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.54	7.82	5.12	1.05	1.81	0.90	0.30	1.35	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	17.91	9.89	6.82	1.07	1.87	0.13	1.60	0.53	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.18	9.32	8.11	1.04	4.32	0.52	0.86	0.69	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.31	8.79	6.08	1.55	1.94	0.00	0.90	1.55	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.59	9.95	6.79	1.94	2.43	0.49	0.97	0.00	0.24	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	11.35	10.84	6.71	0.26	1.29	0.52	0.52	0.00	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	12.66	9.18	6.33	0.95	2.22	0.95	0.95	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.89	14.29	3.85	1.65	2.75	0.55	1.10	0.00	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.50	10.37	8.96	1.18	2.83	0.71	1.41	0.94	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	13.57	10.66	7.11	0.97	1.78	0.48	0.97	1.13	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	17.37	8.14	5.61	1.09	1.45	0.00	0.36	0.90	0.54	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	12.14	7.33	8.58	0.21	1.26	0.84	0.63	0.42	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.83	5.28	8.01	0.78	1.56	0.59	0.20	0.78	0.78	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	11.40	7.17	7.17	1.27	1.69	0.21	0.84	0.00	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.65	8.58	5.11	0.66	1.48	0.49	0.33	0.33	0.16	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.16	8.41	7.29	1.50	0.75	0.56	0.93	0.56	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	13.80	7.47	8.43	1.53	2.87	0.57	0.96	0.19	0.57	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	12.06	6.54	7.56	2.04	1.64	0.61	0.82	0.41	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	11.28	6.85	7.86	1.01	1.01	0.60	0.20	0.40	0.81	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.96	7.02	8.10	0.00	2.16	0.54	1.35	0.54	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.40	10.32	9.60	0.72	1.92	1.20	1.68	0.00	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.00	8.00	10.12	0.47	1.88	0.00	0.24	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.91	7.91	4.54	2.20	1.02	0.59	0.29	0.44	0.73	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.55	3.59	7.17	0.84	1.69	0.42	0.63	0.42	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.89	6.47	9.27	1.40	2.27	0.00	0.70	1.05	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	14.46	7.43	10.84	1.00	3.21	1.20	1.41	0.40	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	13.03	8.61	10.70	0.70	1.16	1.16	1.16	0.00	0.70	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	16.07	8.40	9.36	0.48	2.88	0.24	1.44	0.00	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	13.11	3.28	9.84	0.60	2.98	0.30	0.60	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	16.28	7.90	7.66	2.15	1.44	0.72	1.44	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.32	6.67	10.72	0.40	2.02	0.61	0.81	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	13.53	6.76	6.56	2.66	0.82	1.23	0.82	0.41	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	15.12	10.23	8.67	1.56	1.78	0.44	1.11	0.22	0.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	55.97	0.00	13.99	0.00	0.00	0.00	0.00	0.00	69.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	10.65	7.45	9.58	1.77	1.77	0.35	0.71	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.93	5.96	7.29	0.99	0.66	0.33	0.33	0.33	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.01	20.97	1.68	1.68	0.00	0.00	0.00	0.84	0.00	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.04	9.18	4.59	1.38	0.92	0.92	0.46	0.00	0.00	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.40	8.10	6.81	0.65	2.59	0.32	0.97	0.97	0.97	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.31	4.82	7.07	2.89	1.28	0.96	0.64	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	20.75	18.55	1.26	1.26	0.31	0.94	0.00	0.31	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	11.28	5.64	7.76	1.41	0.71	0.71	2.12	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	15.70	4.49	6.73	2.24	4.49	0.56	1.12	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	42.20	26.27	1.59	0.80	1.59	0.80	0.80	0.80	0.00	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	16.65	14.95	3.06	1.36	0.68	1.02	0.00	0.68	0.34	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	13.32	8.77	5.20	1.62	1.62	1.30	1.62	0.65	0.32	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	13.13	10.65	3.55	2.13	2.84	1.06	0.00	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	129.31	96.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	48.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	110.56	55.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.21	11.21	9.26	0.00	1.95	0.49	0.49	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	10.91	4.96	6.45	1.49	0.50	0.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.07	7.97	8.91	0.47	0.47	0.47	0.94	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	26.16	10.27	2.98	0.99	1.32	0.33	0.33	0.00	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.14	8.35	7.73	0.93	1.24	0.62	1.24	0.00	0.00	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.06	10.09	7.95	0.61	2.75	0.92	0.31	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	28.83	14.89	22.33	4.12	2.06	1.90	3.17	2.22	3.48	0.32
Adipocyte - breast, donor2	11327-117E4	41.07	14.44	13.64	3.37	2.89	1.93	2.73	1.60	1.76	0.48
Adipocyte - omental, donor1	11473-119C6	47.84	14.76	27.99	4.83	2.29	1.91	5.09	2.42	1.78	0.25
Adipocyte - omental, donor2	11474-119C7	48.59	8.22	32.89	2.24	4.48	2.99	5.23	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	54.26	17.42	17.08	3.35	2.68	3.01	2.68	1.67	1.34	0.67
Adipocyte - perirenal, donor1	11476-119C9	39.56	18.50	8.93	3.19	1.91	1.91	3.19	1.28	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	1.10	1.10	1.10	0.00	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	19.87	7.68	6.77	3.16	1.81	0.90	0.00	0.45	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	20.51	7.30	4.34	2.09	0.87	1.04	0.70	0.70	0.87	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	48.70	21.51	12.32	3.72	2.74	2.93	2.35	2.35	0.78	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	31.92	17.50	10.30	4.89	1.03	2.06	1.29	2.32	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	35.40	15.61	8.64	6.97	2.79	1.95	0.56	1.39	1.67	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	39.97	17.63	14.70	6.47	2.94	5.88	2.94	1.18	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	35.87	14.80	10.22	4.75	1.61	2.41	1.61	1.45	1.05	0.56
Adipocyte differentiation, day08, donor2	13023-139D8	19.04	14.85	7.75	3.87	0.32	0.97	1.94	1.61	1.94	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	26.66	10.66	8.53	2.13	1.60	1.07	1.07	1.07	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	29.49	14.47	5.56	0.00	2.23	1.67	0.56	0.56	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	27.03	6.65	4.99	1.66	1.66	3.74	1.66	1.66	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	21.35	12.81	7.79	4.02	1.26	1.00	0.50	0.75	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	18.65	10.80	7.53	2.62	1.64	2.29	1.64	0.33	0.65	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	16.14	7.31	6.39	2.74	0.61	0.61	0.30	0.91	1.22	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	17.68	7.73	6.85	3.31	4.86	0.88	1.55	0.66	0.00	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	9.68	4.30	2.51	2.87	1.79	0.36	0.36	0.72	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	1.20	0.00	1.20	1.20	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	25.91	10.61	16.73	9.89	3.06	0.36	1.98	1.62	0.36	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	11.71	8.37	3.35	1.67	0.00	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	22.19	9.45	10.68	5.55	2.05	0.00	1.44	1.03	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	26.55	15.10	9.27	1.95	2.75	1.72	0.46	1.14	0.69	0.23
Anulus Pulposus Cell, donor2	11463-119B5	26.69	12.49	4.90	1.71	1.22	0.24	0.24	0.73	0.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.33	6.29	5.39	4.94	0.90	0.90	0.45	1.35	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	17.37	9.55	4.34	4.34	0.87	1.30	0.00	0.87	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	8.56	4.28	0.00	0.00	2.14	4.28	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.05	7.47	4.78	2.09	1.20	0.90	0.90	0.90	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	8.85	8.85	6.32	2.53	2.53	0.00	1.26	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	6.60	3.96	5.28	2.64	0.00	1.98	0.66	1.32	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.32	12.02	2.60	1.30	0.65	1.62	0.00	1.30	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.50	11.65	3.40	5.83	0.49	1.94	1.46	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.91	8.31	4.75	0.00	0.59	0.59	0.59	1.78	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	12.81	5.65	4.52	2.64	2.26	1.13	0.38	0.38	0.75	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.24	15.24	2.18	3.63	2.18	0.73	2.90	2.18	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	12.54	6.27	3.76	3.76	1.25	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	13.18	7.58	4.45	1.81	0.99	2.80	0.66	0.49	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	13.65	13.65	2.73	4.09	0.00	1.36	1.36	1.36	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.44	7.24	4.22	3.32	1.51	1.66	1.06	0.75	0.60	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.61	10.72	1.61	3.75	0.00	0.54	0.54	1.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.23	9.26	3.40	3.59	2.08	1.32	0.38	1.13	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.29	6.95	4.28	2.14	0.53	0.80	1.07	0.53	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	9.75	9.75	7.80	0.98	1.95	0.98	0.00	0.98	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.45	7.46	4.48	4.64	1.33	0.83	0.00	0.50	0.66	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	6.00	6.00	1.20	0.00	2.40	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	7.08	14.16	3.54	7.08	0.00	3.54	3.54	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.95	7.89	4.63	4.29	1.37	1.54	0.51	0.51	0.69	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	8.39	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	9.71	3.88	1.46	1.46	0.49	0.49	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	16.70	6.83	4.55	1.90	1.14	1.14	1.14	0.76	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	8.48	12.11	2.42	1.21	2.42	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	13.68	11.97	9.12	3.99	1.71	0.57	1.14	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.54	9.41	6.41	1.92	0.64	0.86	0.43	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.65	7.23	5.16	2.06	1.03	1.29	0.77	0.26	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.48	9.85	3.28	3.28	1.88	1.88	0.94	0.94	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	17.04	8.68	3.54	3.54	0.96	1.29	0.64	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	10.70	7.13	4.99	3.57	1.43	0.00	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	16.96	11.11	2.34	7.02	0.58	0.58	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	10.84	8.43	7.83	3.31	0.30	1.51	0.60	0.90	0.00	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	16.63	11.88	2.38	3.56	3.56	0.00	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	15.77	5.59	3.05	4.07	0.51	0.51	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.52	12.23	3.31	3.31	0.25	0.76	0.51	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	8.90	3.18	3.18	0.64	1.91	0.00	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.24	6.47	5.18	2.16	0.00	0.86	0.00	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	10.80	9.31	3.81	1.69	1.27	1.27	0.85	0.42	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.12	7.25	2.32	2.32	0.29	0.58	0.58	0.58	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	6.61	11.34	10.39	2.83	0.00	2.83	1.89	2.83	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	12.38	10.34	4.07	1.19	1.02	2.37	0.51	0.85	0.51	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	11.58	9.27	4.63	0.00	2.32	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	8.45	6.34	6.34	0.00	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.43	7.08	4.07	4.07	0.43	0.86	1.07	1.07	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.62	11.43	4.21	0.60	0.00	0.60	0.60	1.20	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	4.37	1.46	3.64	2.19	0.73	1.46	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	16.09	7.13	5.75	2.76	0.23	2.30	1.38	0.46	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	10.20	5.10	2.55	0.00	0.00	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	11.44	7.12	6.36	2.03	0.76	0.76	1.27	0.76	0.76	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.13	8.26	6.61	4.13	0.83	2.06	0.21	1.03	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	9.49	8.87	4.28	2.45	1.22	0.92	0.92	1.22	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.25	8.13	3.35	4.30	0.00	1.43	0.48	0.96	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.97	6.21	7.76	2.22	1.11	0.89	0.89	0.67	0.44	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	12.21	3.05	3.05	0.00	1.53	3.05	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.83	9.42	4.43	1.11	1.11	2.22	0.55	0.55	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	10.59	9.27	6.36	1.59	1.06	0.53	0.79	0.53	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.00	2.91	6.18	1.45	1.09	1.45	0.73	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	25.18	10.07	6.14	2.58	1.23	1.84	0.98	0.86	0.37	0.74
Astrocyte - cerebellum, donor2	11580-120F5	28.58	14.04	7.36	2.74	2.05	1.71	0.86	1.03	0.68	0.17
Astrocyte - cerebellum, donor3	11661-122F5	14.89	8.39	2.31	0.63	1.05	0.63	0.42	0.63	0.42	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	23.36	11.15	12.20	1.39	3.83	2.09	1.05	0.70	0.00	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	32.03	17.15	12.78	2.43	3.56	2.26	1.94	1.29	1.29	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	28.64	16.71	14.77	3.13	3.28	1.49	1.34	1.64	0.45	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	1.32	0.88	0.15	0.15	0.29	0.00	0.15	0.15	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	19.84	6.47	5.82	1.08	0.43	0.43	0.22	0.22	0.43	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	13.26	5.49	2.74	1.37	0.46	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	35.87	7.17	0.00	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	19.46	11.30	0.63	4.39	1.88	0.63	0.63	1.88	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	24.75	10.19	4.16	3.95	0.83	0.42	0.42	0.42	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	15.43	8.06	5.76	2.07	0.92	0.00	0.69	1.15	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	24.83	19.07	7.74	1.44	0.90	0.36	1.08	0.54	0.36	0.72
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	0.56	0.00	0.00	0.00	0.56	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	0.00	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	0.00	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	0.00	0.17	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	0.00	1.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	0.00	0.00	0.00	0.00	0.00	0.00	0.15	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	9.01	2.87	1.23	0.00	0.00	0.41	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	0.00	0.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.00	0.00	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.49	0.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.25	0.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	0.92	0.23	1.84	0.46	0.00	0.46	0.00	0.00	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1.44	0.24	1.20	0.00	0.00	0.48	0.00	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	0.55	1.37	0.27	0.27	0.00	0.27	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	1.20	1.50	0.30	0.90	0.00	0.00	0.00	0.30	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	0.96	0.96	1.20	0.48	0.48	0.48	0.48	0.00	0.24	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	0.45	1.59	0.68	0.45	0.00	0.45	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	1.96	1.30	0.43	0.00	0.00	0.65	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	1.05	0.26	0.79	0.00	0.26	0.26	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	0.70	1.17	0.47	0.70	0.00	0.23	0.00	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2.72	0.30	2.11	0.60	0.00	0.60	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	1.45	1.45	1.16	0.29	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	1.07	1.60	0.00	0.53	0.00	0.27	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.50	2.63	3.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	3.64	0.46	0.46	0.00	0.00	0.00	0.00	0.00	0.00	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1.49	1.49	1.49	0.00	0.00	0.00	0.75	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	1.08	1.08	1.80	0.00	0.36	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	0.58	1.44	1.15	0.58	0.00	0.29	0.29	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	0.47	0.00	0.47	0.00	0.00	0.47	0.71	0.00	0.00	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	1.27	2.54	0.95	0.63	0.00	0.32	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	1.23	0.92	1.54	0.00	0.00	0.31	0.31	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	0.64	1.60	2.24	0.32	0.00	0.64	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	1.15	0.76	0.38	0.76	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	1.58	1.18	0.79	0.00	0.39	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	0.00	0.76	0.00	0.00	0.00	0.00	0.76	0.00	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	4.01	7.23	3.21	0.00	0.00	0.00	0.00	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	0.70	0.70	2.80	0.00	1.40	0.00	0.70	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	4.01	3.01	2.00	0.00	1.00	0.00	0.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	89.56	18.28	7.31	3.66	0.00	1.83	0.00	1.83	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	17.29	14.82	14.33	1.48	0.49	2.96	0.99	1.98	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	19.57	7.89	13.15	3.16	1.89	1.58	1.05	0.63	0.63	0.11
Chondrocyte - de diff, donor1	11261-116G1	54.08	15.25	7.28	1.39	2.08	1.39	1.39	1.73	1.73	0.69
Chondrocyte - de diff, donor2	11338-117F6	22.74	9.60	8.88	2.84	0.71	1.78	1.07	1.42	1.42	1.07
Chondrocyte - de diff, donor3	11410-118E6	34.59	13.99	9.90	3.41	3.19	1.93	1.82	1.02	1.25	0.34
Chondrocyte - re diff, donor2	11339-117F7	14.32	7.16	7.16	2.69	1.79	3.58	2.69	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	23.86	11.73	8.09	1.21	1.62	4.04	1.21	1.21	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	25.36	15.38	23.07	2.98	3.10	1.95	0.92	1.26	0.46	1.84
Ciliary Epithelial Cells, donor2	11323-117D9	24.16	14.75	17.74	1.71	2.78	0.86	0.21	1.50	0.00	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	28.58	13.54	21.33	2.83	2.12	1.68	0.97	2.21	0.44	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	30.35	23.75	18.98	4.49	3.85	3.85	1.47	1.74	0.83	1.56
Corneal Epithelial Cells, donor1	11526-119I5	16.69	4.61	3.51	1.10	0.66	0.22	0.22	0.22	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	22.75	7.96	3.41	3.41	0.00	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	22.50	12.53	7.16	0.77	2.05	1.53	1.02	0.77	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	1.33	2.00	1.67	0.33	0.33	2.33	0.67	0.00	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	4.69	0.59	1.17	0.00	0.00	0.59	0.00	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	1.98	2.26	0.28	0.57	0.57	1.41	0.85	0.00	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	2.36	3.54	1.18	1.97	0.39	1.18	0.79	0.00	1.57	0.00
Endothelial Cells - Artery, donor1	11264-116G4	2.04	2.91	0.87	0.29	0.00	0.87	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	4.94	4.24	1.65	1.18	2.35	3.06	0.94	0.00	1.41	0.00
Endothelial Cells - Artery, donor3	11413-118E9	1.23	2.10	0.88	0.35	0.88	0.35	0.35	0.35	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	1.33	3.32	0.66	0.00	0.44	1.11	0.22	0.44	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	3.04	3.96	0.91	1.22	0.30	0.30	0.61	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	1.97	2.54	0.85	0.85	0.56	1.69	0.28	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	2.97	2.38	1.49	0.30	0.89	4.46	1.49	0.30	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	3.64	2.08	1.56	2.60	0.00	0.00	1.56	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	1.99	3.40	1.70	0.14	0.43	7.23	1.42	0.00	2.27	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	5.60	2.00	2.40	2.00	0.40	4.00	0.40	0.40	1.60	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	1.57	1.05	0.52	0.00	0.00	2.10	0.00	0.00	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	5.22	6.21	1.86	2.36	1.99	8.45	0.50	0.25	1.62	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	4.56	4.56	2.39	2.61	1.09	4.78	1.09	0.22	1.74	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	5.50	5.25	3.54	2.56	2.20	8.67	1.47	0.24	1.71	0.12
Endothelial Cells - Vein, donor1	11267-116G7	0.00	2.28	0.00	1.14	0.00	2.28	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	2.10	2.10	1.40	2.79	0.70	0.70	0.70	0.00	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	3.14	3.93	2.04	1.73	0.94	3.30	0.31	0.00	0.47	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	14.17	10.26	6.84	3.66	0.73	1.22	0.73	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	8.32	2.08	2.08	0.00	0.00	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	41.05	21.76	11.90	4.93	2.46	1.64	2.87	1.64	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.53	2.96	7.34	1.20	2.19	0.55	1.09	0.33	0.44	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	20.58	11.16	9.21	3.25	1.95	3.25	1.08	0.76	0.54	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	24.86	11.04	8.61	3.76	2.43	2.18	1.82	1.46	1.46	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	31.52	13.10	9.28	2.59	1.50	1.91	1.09	1.50	0.27	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	26.79	11.92	9.60	2.74	0.74	1.05	1.69	0.63	0.95	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	30.83	17.39	4.22	4.22	0.53	2.37	1.32	0.53	0.79	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	30.23	7.97	7.64	6.31	3.99	1.33	2.33	1.00	0.33	1.00
Fibroblast - Cardiac, donor1	11268-116G8	19.96	9.98	12.70	2.27	5.90	1.36	1.36	0.00	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	11.37	6.06	6.82	0.76	0.76	2.27	0.76	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	12.93	4.26	5.84	2.37	1.42	0.79	0.95	0.79	0.79	0.00
Fibroblast - Cardiac, donor4	11452-119A3	33.95	17.28	22.73	5.76	6.06	2.42	3.33	2.73	2.42	1.21
Fibroblast - Cardiac, donor5	11456-119A7	20.30	14.97	7.74	2.92	1.52	1.90	1.90	1.14	1.14	0.00
Fibroblast - Cardiac, donor6	11460-119B2	19.25	10.61	9.55	4.24	2.43	4.70	1.82	0.91	0.76	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	29.48	11.66	7.64	3.75	2.14	1.34	1.34	0.94	0.54	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	27.18	17.69	9.49	2.59	1.29	1.73	0.86	0.00	1.73	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	11.72	8.79	13.18	8.79	0.00	0.00	0.00	2.93	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	25.14	9.23	14.76	1.61	5.30	1.61	1.38	1.61	0.69	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	29.17	17.81	13.74	2.04	2.20	1.53	1.87	1.70	0.34	0.34
Fibroblast - Dermal, donor1	11269-116G9	30.05	11.27	8.92	3.29	1.41	1.41	0.70	1.17	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	10.85	7.55	3.77	2.36	1.42	0.47	1.42	1.42	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	30.71	13.18	10.88	3.14	2.18	1.69	0.97	0.48	0.85	0.12
Fibroblast - Dermal, donor4	11450-119A1	32.22	21.14	7.91	4.07	3.05	1.24	1.81	1.58	1.02	0.79
Fibroblast - Dermal, donor5	11454-119A5	34.54	26.87	9.25	9.42	2.62	1.40	1.40	1.57	0.70	0.52
Fibroblast - Dermal, donor6	11458-119A9	40.12	24.85	11.53	6.33	3.09	1.30	3.90	2.11	0.97	1.30
Fibroblast - Gingival, donor1	11237-116D4	53.31	21.45	11.04	4.79	4.37	2.29	1.67	1.04	0.83	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	47.42	26.72	22.27	8.38	1.83	3.67	1.05	4.45	2.36	0.00
Fibroblast - Gingival, donor2	11318-117D4	37.29	21.61	10.67	8.43	5.67	2.24	1.98	1.98	0.92	0.79
Fibroblast - Gingival, donor3	11394-118C8	56.47	23.40	10.83	5.03	5.80	2.22	0.97	2.51	1.55	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	59.22	21.82	24.93	8.31	4.16	2.08	1.04	7.27	2.08	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	41.41	19.03	13.57	4.41	2.64	1.76	0.35	1.23	1.41	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	39.91	24.01	18.08	7.33	2.49	0.78	2.49	3.27	1.25	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	32.18	24.75	9.33	6.76	2.43	1.08	2.03	2.70	1.35	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	59.64	39.17	13.41	8.82	3.88	2.12	2.12	3.88	1.76	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	34.95	20.04	11.55	6.00	1.46	1.02	1.46	3.66	0.88	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	32.86	24.13	10.64	7.09	2.86	2.05	0.82	2.18	0.95	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	29.73	27.20	13.38	7.24	2.52	1.97	2.41	2.85	1.54	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	55.03	44.02	17.46	4.40	3.52	2.49	1.91	1.17	1.76	0.59
Fibroblast - Lung, donor1	11270-116H1	9.52	6.80	4.08	0.00	4.08	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	47.75	25.37	19.40	5.97	2.98	1.49	8.95	1.49	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	35.88	21.10	15.19	3.59	4.85	0.21	1.27	1.48	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	3.33	4.17	3.33	0.83	0.00	1.67	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	4.20	4.20	5.59	2.80	1.40	0.00	1.40	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	9.24	5.32	1.68	2.80	0.00	0.00	0.00	0.84	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	34.91	12.99	9.74	5.28	4.87	0.00	1.62	0.00	1.22	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	23.97	0.00	0.00	3.99	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	23.83	17.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.98	26.38	9.31	6.40	6.40	0.39	2.33	0.58	0.58	1.55
Fibroblast - Periodontal Ligament, donor2	11319-117D5	43.23	26.85	15.93	5.76	7.13	1.21	1.97	2.28	1.37	1.06
Fibroblast - Periodontal Ligament, donor3	11395-118C9	36.72	18.05	9.79	7.65	3.67	1.53	3.06	2.45	1.53	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	33.96	20.23	8.78	2.67	3.05	0.76	2.29	2.67	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	39.69	19.17	14.85	1.89	3.51	1.35	2.70	2.43	1.62	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	59.49	25.17	17.51	3.25	4.52	1.86	1.39	1.74	2.20	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	16.69	9.73	5.86	2.87	2.21	1.44	0.88	0.99	0.88	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	23.16	13.61	18.08	4.06	3.05	0.20	1.63	0.61	0.81	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	16.04	9.35	2.00	4.01	2.00	0.67	0.00	2.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	16.61	12.65	11.47	1.98	0.40	0.00	0.79	0.79	0.40	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	65.49	39.49	11.71	7.14	2.98	1.39	1.79	3.18	0.99	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	30.91	13.85	12.43	2.84	3.55	1.24	1.60	1.60	0.18	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	36.66	17.93	16.75	4.14	2.37	0.59	2.96	1.58	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	40.01	26.17	11.73	5.11	1.20	2.11	1.20	1.81	0.30	0.90
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	45.12	24.72	10.80	5.40	2.05	1.73	1.19	1.19	0.43	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	54.66	26.32	7.09	4.81	2.28	1.52	0.51	1.77	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	35.28	13.13	9.02	4.76	2.13	1.97	0.98	2.30	0.49	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	38.10	24.66	16.84	6.02	1.60	3.81	0.80	2.41	1.20	1.80
Fibroblast - skin normal, donor2	11561-120D4	39.48	19.69	11.75	4.92	2.11	2.41	2.11	1.81	1.21	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	77.07	42.62	16.93	6.04	1.51	3.02	1.51	3.63	0.91	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	34.55	17.98	15.08	5.14	3.81	0.99	2.15	2.07	0.66	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	45.30	22.91	16.92	6.50	4.62	2.39	1.88	2.39	0.17	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	39.74	32.19	7.23	3.94	0.66	0.99	1.31	1.31	0.99	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	37.07	18.11	11.72	4.05	2.13	1.28	2.56	2.24	0.96	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	28.51	10.12	11.64	7.08	2.53	1.69	1.01	1.35	1.01	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	42.03	18.98	2.51	3.45	0.00	0.78	0.16	1.10	0.16	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	221.60	177.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	69.72	37.48	12.20	1.74	0.00	4.36	0.87	0.00	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	28.78	15.78	9.19	3.12	4.16	1.04	2.08	1.73	0.17	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	28.37	15.61	6.51	2.34	1.82	1.04	1.04	0.78	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	34.49	17.37	10.73	4.85	3.58	1.79	2.04	2.04	1.28	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	30.62	19.14	32.92	5.36	4.59	2.30	3.06	3.83	0.77	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	22.33	17.23	28.71	4.47	3.19	2.55	3.19	4.47	1.28	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	42.50	31.38	14.26	5.42	4.85	1.14	0.86	5.71	0.57	3.99
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	33.37	30.06	40.81	2.21	7.45	4.14	1.38	1.10	0.83	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	36.30	26.26	36.08	2.05	5.02	3.65	2.74	1.83	1.37	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	40.02	27.74	22.78	3.57	6.14	1.78	0.40	2.77	1.39	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	26.43	25.90	35.16	0.79	7.93	4.23	1.32	0.79	0.53	2.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	44.36	30.33	42.73	1.63	5.87	6.20	5.54	1.96	1.63	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	35.38	23.88	8.84	7.08	1.33	0.88	1.77	4.42	0.00	5.75
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	31.09	21.90	22.61	2.83	5.94	1.84	2.26	2.54	0.71	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.05	18.72	26.72	2.83	4.68	2.71	2.34	2.71	0.99	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	29.55	16.65	23.37	2.95	3.49	1.07	1.88	0.81	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.79	18.96	19.95	3.59	3.10	1.73	2.11	2.23	0.99	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	33.22	17.86	19.93	3.88	3.74	3.60	1.25	1.38	0.55	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	18.70	15.25	16.67	2.03	3.46	1.02	1.83	1.42	1.02	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	29.44	20.99	13.92	3.19	3.88	1.14	1.83	1.37	1.14	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	31.02	15.82	15.82	4.86	4.73	0.87	1.62	1.87	0.87	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	37.81	27.10	17.70	6.12	3.72	0.87	2.62	1.09	1.75	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	30.43	16.25	19.21	3.55	1.18	2.36	0.00	0.59	0.59	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	39.42	22.10	23.68	3.66	3.66	3.66	2.23	0.95	1.59	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	29.04	15.42	21.67	3.13	6.70	2.90	1.56	0.67	0.67	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.47	16.74	20.97	3.43	3.43	2.22	1.81	1.61	0.81	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	43.09	18.66	20.36	3.90	3.56	2.71	1.70	2.71	1.19	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	41.59	21.64	23.14	5.59	5.76	2.57	3.28	1.95	2.04	1.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.36	22.37	28.93	3.12	4.16	1.35	1.77	1.87	1.46	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.57	20.49	23.40	2.90	3.59	2.22	0.85	0.68	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	39.95	20.25	24.45	3.54	3.76	2.43	2.10	1.00	0.66	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	35.28	20.47	22.55	3.99	4.08	1.50	2.00	1.83	0.92	0.92
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.71	14.91	20.21	3.47	3.68	1.02	1.63	0.61	1.02	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.77	21.46	21.25	1.86	2.27	1.24	0.62	1.24	0.83	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	40.35	20.87	26.75	3.80	4.50	3.23	1.27	0.69	0.12	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	26.18	14.34	17.18	3.17	4.00	1.33	0.83	1.17	0.33	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	25.13	14.99	18.30	2.20	2.87	1.98	1.10	1.32	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	29.64	17.22	18.94	2.58	3.20	2.46	0.86	0.74	0.74	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	31.77	19.61	15.56	4.70	3.40	1.46	1.13	1.13	0.97	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	29.83	16.36	18.92	3.53	1.92	1.28	0.32	0.32	0.32	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	32.41	15.35	15.35	4.07	3.88	2.75	1.61	0.76	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	21.51	11.86	13.60	3.95	3.48	2.69	1.27	0.95	0.47	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	28.28	17.33	11.56	1.82	3.04	0.61	1.22	1.22	0.61	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	32.09	15.58	15.16	3.35	2.40	3.14	1.36	0.63	0.52	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	19.54	12.30	10.32	2.20	3.07	1.10	1.10	0.22	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	23.29	14.31	12.06	2.52	2.81	1.96	1.68	1.68	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.48	14.26	7.31	4.44	2.04	1.94	1.67	1.57	0.74	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	17.92	11.23	5.35	2.94	1.60	1.07	0.80	0.80	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.38	13.77	5.66	3.67	2.45	1.84	1.53	1.84	1.07	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	30.31	13.60	6.48	4.53	2.07	1.55	0.91	0.39	0.91	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	21.69	10.84	7.05	2.98	1.63	0.54	0.27	0.54	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	25.81	9.40	10.14	3.87	2.21	0.74	0.55	1.11	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.44	11.40	13.82	2.41	3.51	1.54	0.88	1.10	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	24.79	12.89	7.93	4.96	2.98	1.98	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	29.94	18.86	8.44	3.30	3.03	1.32	0.92	0.66	0.53	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.89	16.34	9.28	4.04	1.61	2.42	0.40	0.40	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	32.53	13.72	19.82	2.54	4.32	2.03	1.78	0.51	0.51	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	43.79	30.46	15.33	3.58	5.97	1.00	2.59	2.79	0.40	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	37.13	15.41	22.50	1.39	6.63	0.46	2.77	2.77	0.46	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	38.26	23.73	22.50	4.09	6.34	1.84	2.86	4.09	1.43	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	18.78	14.39	16.90	1.56	2.19	0.63	3.44	0.63	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	18.93	9.61	9.04	1.70	2.26	0.57	1.41	2.83	0.57	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	20.75	16.60	12.45	5.07	3.69	0.92	1.38	3.69	0.00	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	32.17	27.22	4.95	0.00	0.00	0.00	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	42.55	27.85	30.56	2.71	3.87	2.32	3.87	3.87	2.32	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	16.04	32.09	1.60	0.00	1.60	0.00	1.60	3.21	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	60.86	26.08	34.78	3.48	5.22	0.00	1.74	5.22	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	49.47	31.90	18.55	2.28	5.86	2.60	1.63	2.60	2.93	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	41.18	25.12	30.06	2.06	3.29	1.24	1.24	2.06	0.41	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	69.98	19.99	33.32	3.33	16.66	3.33	3.33	3.33	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	40.83	27.96	29.64	1.96	3.08	1.68	1.68	3.64	2.52	2.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	40.86	26.15	24.51	2.61	3.92	0.98	1.31	3.27	1.63	3.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	54.52	25.17	30.20	1.68	4.19	0.84	1.68	1.68	2.52	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	59.16	37.85	24.81	5.09	5.09	2.23	3.82	2.54	1.91	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	50.61	26.83	18.34	3.74	3.74	1.02	1.02	3.40	0.34	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	33.41	10.44	0.00	2.09	2.09	0.00	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	55.55	34.93	37.80	3.44	5.15	1.72	4.01	0.57	1.72	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	39.96	26.64	15.98	1.78	3.85	0.30	2.66	1.48	0.89	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	60.99	23.72	32.19	10.16	6.78	0.00	3.39	3.39	5.08	8.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	58.40	31.07	34.38	4.97	4.97	3.73	2.07	3.73	2.07	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	60.06	25.54	32.68	6.21	5.06	2.76	1.61	4.83	2.07	3.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	79.03	15.81	21.07	5.27	0.00	0.00	5.27	0.00	10.54	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	51.13	26.52	31.14	3.46	2.69	1.54	1.92	1.92	1.54	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	48.90	25.43	27.38	4.89	5.22	0.65	1.30	2.93	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	42.14	22.74	29.43	6.02	4.01	1.34	0.00	1.34	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	57.79	34.29	33.90	1.93	5.39	0.77	0.39	2.70	0.77	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	63.33	37.66	66.76	7.53	6.16	1.71	1.03	5.48	1.37	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	39.76	47.21	2.48	2.48	2.48	0.00	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	58.98	29.73	39.16	0.94	4.72	1.42	0.00	1.89	0.47	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	51.90	30.78	31.38	0.60	4.83	0.60	0.60	1.81	0.00	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	57.48	29.50	39.17	4.07	5.60	0.51	1.02	2.54	0.51	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	58.23	35.90	36.29	4.79	4.39	1.60	3.19	1.99	0.40	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	49.83	35.03	32.56	3.45	8.88	0.99	0.00	2.47	0.00	4.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	48.40	34.23	40.13	2.36	7.08	2.36	1.18	3.54	0.00	10.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	49.59	29.76	35.01	3.50	3.50	1.75	0.58	0.58	1.75	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	50.47	31.16	45.20	3.95	4.83	2.63	0.44	2.19	0.88	3.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	38.15	34.76	43.23	1.70	3.39	0.85	0.00	5.09	0.85	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	48.35	28.05	39.40	3.58	1.79	2.39	2.39	5.37	2.98	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	41.73	19.90	22.32	2.43	3.40	1.46	0.97	2.43	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	26.25	10.27	2.28	2.28	2.28	2.28	2.28	1.14	2.28	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	25.78	9.56	6.24	2.49	2.08	1.25	1.25	1.25	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	17.99	10.12	3.37	2.25	1.12	0.00	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	24.10	14.59	11.42	1.59	1.27	0.63	0.63	0.32	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.87	9.19	5.85	0.00	0.84	0.00	1.25	0.84	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	84.13	48.51	64.40	17.29	19.50	3.60	8.82	9.86	4.64	2.79
Hep-2 cells mock treated, biol_rep2	11899-125E9	95.04	62.96	65.66	13.84	21.44	6.92	8.61	11.14	4.73	1.86
Hep-2 cells mock treated, biol_rep3	11900-125F1	93.50	47.32	64.84	17.97	19.34	4.78	8.19	9.10	3.64	2.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	86.68	53.67	61.10	15.52	18.69	5.90	8.64	10.71	3.28	1.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	96.28	50.93	59.32	22.78	23.86	4.51	10.96	12.46	2.15	1.93
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	90.63	49.51	59.20	12.92	17.01	5.17	9.47	8.83	4.95	2.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	77.46	50.81	37.98	11.58	19.05	5.60	6.60	8.84	1.99	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	66.22	45.80	35.68	15.78	11.49	6.52	7.03	8.75	3.09	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	57.03	37.80	37.16	11.53	10.57	2.56	7.37	7.37	2.24	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	1.12	3.92	0.56	2.80	0.00	1.12	1.12	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	9.52	7.79	2.60	3.03	1.73	0.43	0.43	2.60	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	0.00	2.64	0.00	0.00	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	25.40	11.99	14.81	1.76	2.47	1.06	0.71	1.41	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	5.09	9.44	4.36	2.18	1.45	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	14.69	8.22	7.34	2.97	1.40	1.22	0.87	0.87	0.70	0.17
Hepatocyte, donor1	11523-119I2	30.27	20.58	3.63	4.84	0.00	0.00	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	40.94	35.55	7.54	8.62	2.15	2.15	1.08	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	33.13	28.84	3.68	5.52	0.00	3.07	0.61	1.23	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	102.42	49.46	35.13	5.94	11.71	2.97	2.27	7.87	1.22	2.62
Iris Pigment Epithelial Cells, donor1	11530-119I9	17.29	10.98	6.04	2.20	2.33	0.55	0.41	0.55	0.27	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	0.00	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.00	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.80	0.00	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	35.17	19.01	4.08	4.16	1.06	0.98	1.06	1.47	0.57	0.24
Keratinocyte - epidermal, donor2	11349-117G8	9.96	5.86	1.76	3.51	0.00	0.00	1.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	33.22	15.43	3.98	3.69	2.18	1.23	0.76	0.76	0.38	0.28
Keratinocyte - oral, donor1	11251-116E9	78.67	42.80	21.80	3.97	3.63	1.36	2.16	1.48	0.45	0.79
Keratocytes, donor1	11527-119I6	14.78	13.75	14.44	3.09	1.38	0.34	1.03	1.03	0.00	0.34
Keratocytes, donor2	11607-120I5	16.41	8.20	2.34	7.03	0.00	0.00	3.52	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	22.33	16.60	12.05	2.17	2.77	0.99	0.20	0.79	0.20	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	63.74	2.20	24.18	10.99	0.00	2.20	8.79	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	14.02	10.79	7.55	1.08	4.31	1.08	0.00	2.16	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	18.68	14.65	10.61	2.42	2.88	0.92	0.46	0.46	0.00	0.46
Lens Epithelial Cells, donor3	11690-122I7	25.33	12.82	17.46	2.83	2.42	1.31	1.21	0.81	0.50	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	2.25	5.10	1.66	0.83	0.83	3.56	0.24	0.24	1.07	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	0.84	3.07	2.23	0.28	0.00	2.51	1.12	0.28	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	4.56	6.93	2.05	1.73	0.47	7.24	1.26	0.63	0.94	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.23	3.23	0.00	1.61	0.00	4.84	2.15	0.54	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.15	2.52	0.95	0.32	0.00	1.89	0.95	0.00	0.63	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1.73	3.77	0.43	0.97	0.11	2.91	0.43	0.22	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	3.69	3.28	1.64	0.41	0.00	3.69	0.00	0.82	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	0.76	1.01	0.25	0.25	0.25	2.28	0.76	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	3.10	3.24	0.99	0.84	0.28	4.08	0.14	0.28	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	2.77	1.98	0.79	0.79	0.40	1.58	0.40	0.00	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3.49	5.62	2.71	0.39	0.19	3.30	0.39	0.00	0.39	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.30	2.41	0.93	0.37	0.19	2.41	0.00	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	4.18	3.48	1.05	0.70	0.35	3.83	1.74	0.35	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	2.15	2.15	2.15	1.43	0.24	3.34	1.19	0.00	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	2.47	3.98	1.24	0.41	0.14	2.33	0.14	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	1.85	1.23	2.46	0.92	0.62	4.00	0.92	0.00	1.54	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	2.18	1.87	0.31	0.00	0.00	2.49	0.31	0.00	1.25	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	3.84	3.66	1.28	1.28	0.73	2.20	0.91	0.00	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	4.28	4.94	1.65	0.00	0.99	4.61	0.66	0.33	1.97	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	0.88	2.05	0.00	0.00	0.00	2.34	0.00	0.00	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.99	1.99	1.24	0.75	0.50	2.49	1.00	0.00	1.49	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	2.42	3.39	1.94	0.48	0.97	3.88	0.48	0.00	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	2.96	4.04	0.54	0.54	0.27	3.77	0.54	0.27	0.81	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	3.03	3.03	1.97	1.21	0.15	3.03	0.61	0.15	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	3.63	1.56	2.07	0.00	0.00	2.59	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	1.68	5.03	2.30	0.84	0.84	5.23	0.63	0.42	1.05	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	2.71	2.41	1.05	0.75	0.45	3.61	0.45	0.30	0.75	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.88	5.50	2.06	0.69	0.69	5.50	1.38	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	4.33	2.82	2.07	0.38	0.94	3.01	0.38	0.19	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.07	2.86	2.97	0.64	0.21	2.86	0.53	0.00	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	3.88	5.33	1.94	0.97	0.97	3.88	0.97	0.00	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	1.65	3.31	0.00	0.00	0.33	1.98	0.00	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.23	2.35	1.49	0.87	0.12	3.10	0.62	0.37	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	2.22	7.40	1.85	1.48	0.74	6.66	0.37	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	2.47	3.21	1.98	0.99	0.25	3.95	0.99	0.49	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1.24	2.34	1.10	0.41	0.27	2.06	0.41	0.14	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	2.57	4.50	3.22	1.29	1.61	2.89	0.64	1.29	1.29	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	5.48	5.17	3.35	0.00	0.30	4.26	2.43	0.00	1.52	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	1.96	4.62	3.64	1.26	0.84	4.06	0.56	0.42	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	2.13	1.78	1.07	0.71	0.71	5.33	1.07	0.00	2.13	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	1.45	0.97	0.97	0.00	0.97	2.42	1.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.56	3.58	1.09	0.16	0.16	2.49	0.31	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	3.22	3.94	0.36	1.79	0.72	1.79	0.36	0.00	2.15	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	3.59	3.92	3.27	0.98	0.98	2.94	0.65	0.00	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.65	1.65	1.88	0.47	0.00	1.18	0.00	0.00	0.94	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	2.60	3.59	2.35	1.11	0.74	3.96	1.11	0.00	1.24	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.82	2.31	1.02	0.00	0.26	1.02	0.77	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.28	3.28	1.49	0.60	0.30	3.58	0.00	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	4.53	4.53	0.00	0.00	0.00	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.97	9.97	4.60	1.53	0.00	0.77	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	5.94	2.23	0.74	1.48	2.23	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	6.35	2.12	6.35	2.12	0.00	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.81	4.92	2.81	0.70	2.11	1.41	0.00	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	4.67	2.80	1.87	0.00	0.00	1.87	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	5.15	4.64	2.06	2.06	0.00	0.00	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	4.76	2.38	2.38	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.20	4.52	2.26	1.13	0.90	0.45	0.68	0.45	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.98	6.69	4.65	1.74	0.00	1.16	0.29	0.58	0.00	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.20	7.65	5.40	1.80	1.80	0.45	0.00	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.21	5.55	4.61	2.17	0.27	0.41	0.41	0.68	0.27	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	6.16	6.68	3.08	0.51	0.51	0.51	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.35	3.88	7.41	1.41	0.35	1.06	1.06	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.33	3.33	2.67	0.67	0.00	0.00	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	4.58	6.11	4.08	2.04	0.00	0.51	0.51	0.51	0.51	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.47	5.60	4.54	1.87	1.33	0.53	0.27	1.33	0.27	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	5.86	7.94	5.67	2.46	1.13	0.57	0.38	1.13	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	7.36	4.91	4.29	1.23	0.00	0.61	0.61	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	14.68	8.97	3.26	4.89	0.00	1.63	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	8.95	8.54	7.08	1.46	1.04	0.42	0.42	0.21	0.21	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	8.97	5.04	4.20	1.12	0.28	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	5.15	4.12	1.03	1.03	1.03	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	6.97	8.71	5.81	3.48	0.58	0.58	0.58	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	6.88	2.39	5.08	1.79	0.30	0.60	0.90	0.30	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	7.75	3.87	3.87	2.21	1.66	0.55	0.00	0.00	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.78	10.60	6.36	1.77	1.06	0.71	0.35	0.00	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.11	8.48	4.79	2.21	0.74	0.00	0.74	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	5.76	4.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	6.91	7.68	2.69	1.54	0.00	0.00	0.38	1.54	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	5.66	2.83	3.96	2.26	0.00	1.13	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6.56	6.56	6.56	3.28	0.00	0.00	0.82	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	7.23	6.33	7.68	1.81	0.00	0.90	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.18	3.59	8.62	0.72	0.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	3.73	4.48	7.47	2.24	0.00	0.00	0.75	0.00	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	6.69	5.57	4.46	1.86	0.74	0.74	0.00	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	5.17	4.74	6.89	3.02	0.43	0.43	0.86	0.00	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	10.28	8.56	5.99	4.28	0.00	0.00	0.86	1.71	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	5.33	6.00	7.33	2.67	0.67	0.67	0.33	0.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.84	3.02	6.64	1.81	0.00	1.21	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	6.40	4.98	4.27	0.71	0.71	0.00	0.00	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.28	5.50	5.16	1.72	0.34	0.34	0.00	0.69	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.37	5.37	6.44	0.00	0.00	0.00	1.07	0.54	0.00	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	4.04	3.37	6.73	1.35	0.67	0.67	1.35	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	4.07	6.30	7.78	2.22	0.37	0.00	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	6.98	3.49	1.16	0.00	4.65	0.00	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	8.46	5.29	1.06	1.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	10.80	6.40	6.80	0.40	1.60	0.80	0.40	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	9.45	4.36	5.81	0.73	0.00	0.73	0.00	2.18	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	3.83	10.73	4.60	3.07	2.30	0.77	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	8.39	8.39	3.95	1.97	0.00	0.00	0.00	1.97	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	5.65	2.82	2.82	0.00	0.00	0.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	11.56	9.55	4.53	0.50	1.51	2.01	1.01	1.01	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	9.91	8.11	3.60	0.45	0.00	0.45	0.00	1.35	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	0.00	5.16	1.72	0.00	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	9.80	3.56	3.56	1.78	0.89	0.00	0.45	0.00	0.89	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	10.95	8.60	3.91	1.56	0.39	0.39	1.17	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.24	2.64	4.62	1.32	0.66	0.00	1.32	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.42	8.30	3.63	0.52	0.00	0.52	1.04	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	9.19	7.44	5.69	0.88	0.00	0.44	0.44	0.88	0.00	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.83	4.47	3.91	1.68	0.56	0.00	0.00	0.00	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	10.60	6.18	3.09	1.32	1.32	0.00	0.88	0.44	0.88	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	8.49	6.56	4.24	1.93	0.39	0.39	0.39	0.77	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	8.61	6.08	3.54	1.52	1.01	0.00	0.51	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	7.69	8.17	4.81	0.00	0.48	0.48	0.48	0.96	0.00	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	7.16	3.98	5.57	1.99	0.00	0.80	0.40	1.59	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	5.47	7.29	3.65	1.22	0.61	0.00	0.00	0.61	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	3.46	6.92	2.08	1.38	0.69	0.69	1.38	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	7.22	10.64	5.32	2.28	0.76	0.38	0.38	0.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.36	4.65	3.10	2.07	1.03	0.00	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.65	10.88	6.65	1.81	0.60	0.00	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.24	9.51	8.24	0.63	0.95	0.63	0.63	0.63	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.00	6.40	7.46	2.13	0.00	0.00	0.53	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	6.90	7.47	6.90	0.57	1.15	0.00	1.72	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.23	3.60	8.74	0.51	1.03	0.51	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.07	9.20	7.07	0.71	0.00	0.00	0.00	2.12	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.94	5.67	4.54	2.27	0.57	1.13	0.00	1.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.98	7.49	5.41	0.42	1.66	0.42	1.25	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	6.26	5.48	0.78	0.00	0.00	0.78	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.52	7.52	6.26	1.25	0.00	0.42	0.42	1.67	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.50	9.29	7.90	0.93	1.39	0.00	0.46	0.93	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.02	2.68	2.68	2.68	0.00	0.00	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	6.95	5.35	3.21	2.14	0.00	0.53	1.07	0.00	0.00	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	7.27	8.08	6.06	1.62	0.40	1.21	0.00	0.00	0.00	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	7.34	8.26	4.59	2.75	0.92	0.00	0.92	0.92	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.89	4.45	8.00	1.78	0.00	0.89	0.00	1.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.40	8.55	6.27	1.14	0.00	0.57	0.57	1.71	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	9.20	6.14	1.53	0.77	0.00	0.00	2.30	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	5.47	6.02	4.92	1.09	1.09	0.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.91	11.14	5.35	1.34	0.45	0.45	0.00	1.78	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.06	6.50	6.50	2.08	1.04	0.26	0.78	0.26	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	7.96	7.29	6.63	2.65	1.33	0.00	0.00	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	4.16	6.24	2.08	2.08	0.00	2.08	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.74	10.62	3.72	1.06	3.19	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	36.76	16.64	4.91	4.12	2.54	0.79	1.27	1.74	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	35.86	17.79	2.92	3.89	2.92	0.97	1.25	1.25	0.69	0.42
Mammary Epithelial Cell, donor1	11273-116H4	64.27	26.01	14.45	3.59	3.49	3.49	2.69	1.99	1.40	1.20
Mammary Epithelial Cell, donor2	11350-117G9	51.25	19.69	13.32	6.37	4.05	4.05	2.03	2.61	1.74	0.58
Mammary Epithelial Cell, donor3	11422-118F9	21.45	12.47	4.74	3.99	2.24	0.75	1.00	1.75	1.25	0.25
Mast cell - stimulated, donor1	11487-119E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.68
Mast cell, donor1	11563-120D6	0.00	0.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor2	11565-120D8	2.08	0.59	0.89	0.30	0.30	0.30	0.00	0.00	0.30	0.00
Mast cell, donor3	11566-120D9	0.68	0.45	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	1.24	1.06	0.53	0.00	0.18	0.00	0.18	0.18	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mast cell, expanded, donor8	11941-126A6	0.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	7.36	10.25	2.98	2.19	1.19	7.36	0.70	0.10	1.89	0.30
Melanocyte - dark, donor2	11582-120F7	25.26	13.84	19.03	4.15	0.69	2.08	2.08	1.73	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	17.39	10.21	5.36	2.75	1.38	1.23	0.43	0.87	0.51	0.58
Melanocyte - light, donor1	11274-116H5	19.28	9.40	4.23	2.12	0.94	1.41	0.71	0.47	0.71	0.24
Melanocyte - light, donor2	11351-117H1	12.28	5.46	3.41	0.68	2.73	0.00	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	14.74	5.20	4.34	1.73	1.73	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	24.37	11.35	3.85	4.06	1.04	2.60	0.31	0.21	0.31	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	19.90	12.37	8.07	5.92	1.34	2.15	0.81	1.61	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	27.32	14.46	8.30	4.02	0.54	1.87	1.34	2.41	0.27	1.07
Meningeal Cells, donor1	11493-119E8	25.43	18.36	8.56	7.69	4.09	2.23	1.61	1.98	0.99	0.74
Meningeal Cells, donor2	11573-120E7	20.25	14.52	14.97	3.08	2.64	1.32	1.76	0.88	0.44	0.88
Meningeal Cells, donor3	11654-122E7	22.33	20.46	11.33	5.13	1.79	2.20	1.63	1.63	2.04	0.90
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	28.52	15.11	15.11	2.28	1.43	1.43	2.28	1.43	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	19.62	7.65	22.94	3.82	1.61	0.70	1.71	0.81	0.40	0.70
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	0.00	3.94	1.31	1.31	2.63	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	7.85	1.31	5.23	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	19.38	15.79	7.89	0.00	1.44	1.44	0.00	0.00	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	28.38	12.07	19.06	3.81	2.54	1.48	1.69	0.85	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	28.65	19.10	8.54	4.02	2.01	0.50	0.50	3.02	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	11.65	5.93	11.65	1.76	1.54	0.88	1.54	0.88	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	9.50	10.23	5.11	3.65	1.46	0.00	2.19	1.46	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	15.14	9.21	10.03	1.84	2.25	1.43	0.41	0.82	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	35.60	12.88	8.45	2.22	1.39	1.11	0.97	1.11	0.28	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.66	2.23	6.32	1.12	1.86	0.74	0.00	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	24.47	14.74	12.50	2.89	1.71	0.92	1.05	0.92	0.66	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	14.24	5.93	5.04	1.78	0.59	0.59	0.30	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	7.01	0.00	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	9.61	8.33	3.20	1.28	1.28	0.00	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	28.00	14.18	10.99	3.90	1.42	2.84	1.06	2.13	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	28.15	12.20	10.01	1.88	3.13	0.63	0.63	1.25	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	26.12	13.79	8.71	2.90	2.90	0.73	0.73	0.00	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	36.59	13.52	16.71	4.51	3.71	1.59	1.59	0.80	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	18.02	3.50	12.51	2.50	1.50	0.50	2.00	1.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	36.06	14.60	26.95	5.06	4.91	1.16	1.52	1.08	0.94	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	0.00	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	0.00	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	0.00	0.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	0.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	0.00	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	0.00	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	0.00	0.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	0.00	0.30	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	0.00	0.00	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	0.00	0.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	0.00	0.60	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	0.00	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	0.00	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	0.00	0.00	0.00	0.00	0.00	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	3.26	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.02	9.48	11.85	3.66	2.37	1.08	2.15	1.51	0.22	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	30.31	16.72	12.02	4.70	3.66	0.52	1.05	3.14	0.52	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.69	14.02	14.02	2.67	6.67	2.00	2.67	0.00	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	18.78	10.02	15.03	1.67	5.84	2.50	4.17	1.67	1.67	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	60.27	37.46	4.56	5.89	3.04	1.90	0.76	2.85	0.76	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	38.30	39.90	19.15	15.96	3.19	4.79	0.00	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.24	10.88	12.92	1.36	0.68	0.68	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	152.52	115.77	1.84	3.68	1.84	1.84	0.00	1.84	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.56	6.70	13.81	4.19	3.77	0.84	2.51	1.26	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	23.24	14.41	9.07	3.25	3.72	2.79	1.39	1.16	0.93	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	15.67	9.73	11.62	2.16	3.78	1.08	2.97	1.62	1.08	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	22.07	22.29	8.83	5.47	3.57	1.47	0.84	2.73	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	233.83	211.56	11.13	0.00	0.00	0.00	0.00	0.00	0.00	33.40
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.38	17.37	12.91	2.98	1.99	1.49	2.48	3.47	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	28.15	22.47	5.95	4.06	1.89	1.62	0.54	1.35	0.54	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.31	10.43	10.20	3.40	4.53	1.13	2.49	0.45	0.91	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.33	10.29	16.00	3.10	2.94	2.12	2.45	1.63	0.49	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	22.42	12.03	13.67	6.20	3.28	1.09	1.64	2.73	0.73	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	25.46	11.14	15.38	3.71	3.18	0.53	2.65	1.06	2.65	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.81	4.20	19.81	0.60	4.80	0.60	3.60	0.00	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	62.35	36.43	3.61	11.81	0.66	1.31	0.33	3.94	0.33	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.91	10.08	12.68	1.30	3.09	2.28	2.76	1.30	1.79	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	22.75	16.76	11.64	6.00	2.12	2.47	1.94	3.53	0.35	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	10.55	9.85	20.39	2.11	2.81	2.11	1.41	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.85	9.19	14.25	2.76	2.76	2.30	0.46	0.46	1.84	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	16.07	6.11	23.46	3.86	4.18	1.29	1.61	0.32	1.93	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	68.98	32.42	3.10	3.45	1.03	1.38	0.34	1.03	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	192.16	98.61	0.00	0.00	2.53	0.00	0.00	2.53	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.51	12.70	8.69	4.23	2.45	2.45	0.89	4.46	0.22	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.55	8.89	16.51	1.69	0.85	1.69	1.69	1.69	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	24.45	11.87	6.65	1.90	1.90	3.09	1.42	2.14	0.71	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	20.17	9.44	25.33	2.15	3.00	2.58	1.72	1.29	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	225.69	108.33	9.03	0.00	0.00	0.00	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	23.33	6.00	13.66	2.67	3.33	2.67	1.33	1.00	0.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.98	9.92	13.08	3.61	0.90	0.90	0.90	1.35	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	9.13	10.71	15.87	1.59	1.59	1.19	1.19	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	13.00	8.36	15.79	3.71	0.93	4.64	0.93	0.93	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	24.22	17.78	11.35	3.41	5.68	2.27	1.89	1.51	1.89	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.95	6.52	22.49	1.30	2.61	0.33	3.26	1.30	0.98	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.51	10.02	16.12	2.61	2.61	0.87	3.49	1.31	0.44	1.74
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	21.26	13.12	10.40	6.33	1.36	0.45	2.71	1.36	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	3.53	18.52	4.41	1.76	0.88	1.76	0.00	1.76	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	11.30	11.30	15.96	5.32	2.66	2.66	1.99	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	22.32	8.93	20.34	1.98	3.47	1.49	0.50	1.49	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	13.40	7.66	22.20	3.45	1.15	1.15	0.77	0.77	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	28.73	15.12	9.98	4.23	3.02	2.42	2.12	1.51	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	20.11	14.81	16.13	3.54	1.77	0.66	1.33	1.99	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.20	6.10	18.30	1.36	1.36	1.36	0.68	2.03	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	143.07	45.99	0.00	5.11	0.00	5.11	5.11	10.22	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	15.85	9.15	25.00	3.05	6.71	1.22	2.44	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	17.63	8.18	22.35	1.26	2.20	3.15	2.20	0.63	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.74	8.17	14.22	1.82	2.42	1.21	1.21	0.00	1.51	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	8.70	15.82	0.79	2.37	3.16	0.00	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	63.48	47.61	7.94	6.80	1.13	2.27	1.13	1.13	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	121.39	80.93	0.00	10.12	0.00	5.06	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	15.78	8.57	7.83	2.24	1.99	1.12	0.87	0.62	0.99	1.12
Myoblast, donor2	11322-117D8	29.15	17.07	9.59	3.26	2.11	1.15	1.53	1.73	0.38	0.19
Myoblast, donor3	11398-118D3	21.19	11.44	13.12	3.20	2.86	0.67	2.35	1.68	1.35	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neural stem cells, donor1	11275-116H6	17.06	12.70	17.42	3.27	0.36	1.81	1.45	1.81	1.45	0.36
Neural stem cells, donor2	11352-117H2	19.26	5.78	17.33	5.78	1.93	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	7.97	2.28	28.45	0.00	0.00	1.14	1.14	2.28	0.00	0.00
Neurons, donor2	11574-120E8	7.27	5.06	2.86	0.44	0.88	0.22	0.00	0.22	0.44	0.22
Neurons, donor3	11655-122E8	9.04	1.64	23.84	0.00	0.82	0.00	0.82	0.00	0.82	0.82
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	33.96	18.88	16.98	1.31	2.73	2.85	0.95	1.42	0.71	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	12.05	12.70	8.79	1.30	0.98	0.98	0.65	0.33	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	31.09	12.63	7.62	2.21	1.60	0.60	1.00	1.00	0.60	0.40
Olfactory epithelial cells, donor1	11933-125I7	29.46	21.34	11.43	3.30	1.79	0.28	1.38	2.20	0.55	0.96
Olfactory epithelial cells, donor2	11934-125I8	28.23	21.42	13.03	2.17	2.03	1.59	1.01	2.32	0.58	0.72
Olfactory epithelial cells, donor3	11935-125I9	22.81	17.82	10.33	3.97	3.75	0.57	0.79	1.70	0.68	1.36
Olfactory epithelial cells, donor4	11936-126A1	54.54	40.81	10.71	5.94	4.29	1.66	1.75	1.95	0.78	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	45.74	31.29	13.84	4.81	6.02	0.00	1.20	0.60	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	19.57	4.04	10.42	2.77	1.28	0.21	1.91	0.43	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	16.00	2.29	8.00	3.43	1.14	0.00	1.14	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	6.83	6.21	4.97	1.24	2.48	0.62	2.48	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	14.66	6.25	8.79	2.35	0.59	0.39	0.00	0.39	0.20	0.39
Osteoblast, donor2	11354-117H4	34.41	21.07	25.99	2.81	2.11	1.40	1.40	2.11	2.11	0.70
Osteoblast, donor3	11426-118G4	28.79	12.44	14.93	3.73	2.13	1.42	1.42	0.36	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	36.47	22.91	10.36	4.89	2.78	1.43	1.26	2.11	0.59	0.51
Pericytes, donor1	11491-119E6	11.35	5.23	3.12	1.11	1.00	0.33	0.00	0.11	0.33	0.22
Pericytes, donor2	11571-120E5	16.52	6.56	5.21	1.58	1.13	0.68	0.68	0.23	0.45	0.00
Pericytes, donor3	11652-122E5	18.11	8.34	6.31	2.64	0.81	0.41	1.22	1.02	0.81	0.20
Perineurial Cells, donor1	11499-119F5	22.83	14.69	5.65	3.84	3.73	1.81	0.68	1.13	0.45	0.68
Perineurial Cells, donor2	11579-120F4	28.43	15.46	21.16	3.59	1.20	3.04	1.84	1.84	0.83	0.64
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	0.00	0.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	20.81	9.81	6.46	2.63	1.91	0.24	0.96	0.96	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	18.85	12.20	9.98	1.11	5.54	0.00	3.33	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	25.72	9.82	14.33	2.94	4.12	0.79	0.59	2.16	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.32	11.71	13.61	0.95	3.48	0.63	3.16	0.63	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	19.88	6.57	14.82	4.31	2.06	0.94	1.31	1.13	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	34.20	16.32	13.05	3.52	1.44	1.83	1.44	2.48	0.26	0.78
Preadipocyte - breast, donor2	11328-117E5	36.02	14.63	16.44	3.15	4.28	1.58	2.70	2.48	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	34.63	17.37	21.52	5.97	3.09	2.77	3.41	2.02	1.17	0.53
Preadipocyte - omental, donor2	11329-117E6	29.24	14.40	20.08	3.49	6.11	1.31	1.75	1.31	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	41.40	15.47	22.20	3.44	4.01	2.86	2.72	3.01	0.72	0.57
Preadipocyte - perirenal, donor1	11469-119C2	24.61	5.91	10.83	3.94	0.98	0.98	1.97	2.95	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	16.89	4.91	8.91	2.76	0.00	0.00	0.92	1.23	0.61	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	37.54	21.43	24.44	5.84	3.01	3.72	1.42	1.06	0.53	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	34.40	11.92	18.22	5.11	1.70	2.21	1.19	1.53	0.68	0.17
Preadipocyte - visceral, donor1	11280-116I2	42.10	25.24	20.96	7.73	3.07	2.70	3.45	1.77	1.77	0.37
Preadipocyte - visceral, donor2	11357-117H7	26.69	20.71	23.47	5.98	1.38	2.30	1.38	1.84	2.30	0.92
Preadipocyte - visceral, donor3	11429-118G7	33.96	17.55	16.30	5.12	2.93	1.67	1.99	1.15	0.63	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	104.99	35.75	53.70	7.54	12.52	5.13	3.92	8.00	1.96	4.68
Prostate Epithelial Cells, donor2	11331-117E8	30.06	16.93	8.12	4.20	2.44	1.49	1.08	0.68	1.08	0.41
Prostate Epithelial Cells, donor3	11404-118D9	41.03	18.31	6.18	3.43	3.43	1.10	1.35	0.73	0.37	0.37
Prostate Stromal Cells, donor1	11254-116F3	36.90	12.07	9.23	1.94	2.28	0.57	1.25	2.05	0.46	0.34
Prostate Stromal Cells, donor2	11332-117E9	32.81	18.11	10.22	5.02	1.43	1.43	1.61	1.79	0.72	1.26
Prostate Stromal Cells, donor3	11405-118E1	32.22	14.39	13.35	2.40	2.40	1.25	1.46	1.04	0.63	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	16.42	7.30	4.74	3.65	1.46	1.09	1.09	1.46	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.00	13.79	6.65	4.30	2.01	0.42	0.97	0.55	0.28	0.28
Renal Epithelial Cells, donor1	11517-119H5	10.65	4.57	6.59	3.55	3.55	2.03	1.01	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	11.38	10.67	4.27	2.85	0.71	0.71	2.85	1.42	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	24.77	17.04	8.15	2.75	2.33	0.64	1.69	0.53	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	0.68	1.36	0.68	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	0.94	0.54	0.27	0.54	0.13	0.40	0.13	0.00	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.10	11.10	5.99	4.88	0.44	2.44	1.11	0.89	0.44	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	2.66	3.99	0.00	0.00	1.33	0.67	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	15.85	6.38	14.09	2.86	1.10	1.10	0.44	0.44	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	17.56	6.27	13.79	3.13	0.00	0.63	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	7.77	3.88	6.38	0.83	1.11	0.00	0.28	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	21.74	9.13	4.83	5.37	2.15	0.27	2.42	1.07	0.00	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	17.29	10.12	2.53	3.80	2.53	0.42	0.00	0.84	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.62	12.54	7.52	3.09	3.09	0.96	0.58	0.96	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.04	13.22	6.74	1.81	4.41	0.78	1.30	2.07	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.95	5.12	9.38	1.42	1.42	0.57	0.28	0.85	0.28	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	3.09	3.09	3.09	2.06	1.03	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.03	4.77	8.53	2.26	1.00	0.75	0.50	0.00	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	50.38	24.86	9.49	3.47	4.28	2.54	1.87	0.40	0.67	2.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	2.68	3.57	0.89	1.79	0.89	0.00	1.79	0.89	0.00	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.15	11.01	1.65	2.20	0.55	0.00	0.00	2.20	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	11.60	4.64	6.38	0.58	0.58	0.00	0.58	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	4.16	5.07	2.73	3.25	1.69	0.65	0.26	1.17	0.39	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	6.16	3.87	4.37	2.48	2.88	0.40	0.70	1.79	0.20	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	5.69	5.24	3.35	1.67	2.57	0.56	0.89	0.67	0.45	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	7.32	8.31	3.35	3.85	3.97	0.12	1.24	1.24	0.37	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	5.94	5.83	4.78	1.86	3.03	0.58	1.40	1.05	0.12	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	7.63	6.70	2.77	2.31	3.70	0.23	0.46	1.85	0.46	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	3.70	4.79	3.97	2.05	2.33	0.68	0.55	1.23	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	5.60	4.84	4.69	1.97	3.03	1.36	1.51	1.51	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	6.09	5.91	4.84	1.43	3.05	0.90	0.72	0.36	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	5.59	5.16	3.01	0.86	2.73	0.72	1.58	0.86	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	4.19	3.33	3.54	1.29	2.25	0.43	1.50	1.07	0.32	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	4.65	6.20	3.10	1.99	2.43	0.22	0.44	1.99	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	4.21	6.12	2.68	3.25	1.15	0.00	0.76	1.15	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	5.40	4.19	4.38	2.14	2.61	0.75	1.21	0.93	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	4.89	5.45	3.19	1.50	2.44	0.38	1.50	1.32	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	4.64	5.57	3.72	3.18	2.26	0.53	1.06	0.66	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	6.91	6.42	3.60	2.24	2.82	0.19	0.97	1.07	0.39	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	6.68	6.49	3.63	0.57	2.48	0.38	0.95	0.57	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	4.49	5.45	2.46	3.74	2.24	0.64	0.75	0.32	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	5.61	4.48	3.64	1.96	3.36	1.12	0.28	1.12	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	5.13	5.13	3.25	1.03	1.71	0.68	1.03	1.20	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	5.29	5.83	2.55	1.46	0.73	0.36	1.09	1.09	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	5.15	6.01	4.66	1.96	2.58	0.49	0.86	0.86	0.49	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	5.24	3.49	3.76	2.15	2.82	0.54	0.81	1.61	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	2.59	4.95	2.83	1.89	1.42	0.47	1.18	1.89	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	3.17	4.76	5.16	2.18	3.17	0.60	1.39	2.18	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	4.44	6.08	7.25	2.34	3.04	0.94	0.47	1.40	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	4.35	4.98	3.73	2.07	2.07	0.41	1.66	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	4.42	3.98	5.75	1.55	1.33	0.88	1.55	0.66	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	4.60	2.92	3.97	2.72	3.34	0.84	0.63	1.46	0.21	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	4.17	4.71	4.71	3.77	1.48	0.40	0.81	0.94	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	5.62	4.77	5.62	3.75	1.87	0.51	0.85	2.72	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	5.78	5.01	5.21	2.31	1.16	0.39	0.77	1.54	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	4.13	7.05	3.95	2.92	2.24	0.34	0.34	1.38	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	3.70	4.53	3.15	3.29	1.23	0.82	0.82	2.47	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	4.93	5.58	2.96	2.30	1.64	0.49	0.66	3.12	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	4.60	3.75	3.75	2.56	0.85	0.51	1.53	0.51	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	4.14	4.88	4.14	1.48	3.11	0.59	0.74	1.33	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	4.26	5.33	4.00	1.60	3.20	0.53	1.87	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	5.39	3.04	3.59	1.24	1.66	0.55	0.41	0.55	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	4.05	2.86	4.29	1.19	3.33	0.95	0.48	0.71	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	6.85	9.27	4.64	2.22	2.62	1.21	1.81	1.41	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	2.73	2.07	3.01	1.32	1.04	0.85	0.85	0.28	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	3.84	1.40	5.59	1.40	2.79	0.00	0.35	1.05	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	3.93	4.23	4.53	1.81	0.91	0.60	0.91	0.91	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	4.16	3.30	1.84	1.35	1.35	0.49	0.98	0.49	0.49	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	6.26	4.95	5.97	3.20	2.62	0.58	0.87	1.31	0.29	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	4.87	5.48	4.26	1.22	2.43	0.00	1.22	1.22	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	3.32	4.52	4.22	1.21	0.60	0.30	0.90	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	3.62	2.04	4.98	0.90	0.90	0.23	1.36	0.45	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	5.39	4.19	4.19	1.20	1.20	0.90	1.20	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	3.19	2.60	1.65	1.30	0.71	0.35	0.94	0.71	0.24	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	2.99	1.92	2.13	0.64	2.13	0.21	0.00	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	5.41	3.61	2.40	1.80	0.60	0.00	1.20	0.00	0.60	1.80
Schwann Cells, donor1	11498-119F4	16.17	7.15	3.57	2.44	1.32	0.75	0.19	0.19	0.38	0.19
Schwann Cells, donor2	11578-120F3	34.02	20.41	6.80	3.40	0.00	3.40	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	19.50	15.34	3.72	3.94	3.29	1.53	2.85	0.66	1.10	0.22
Sebocyte, donor1	11220-116B5	30.68	15.89	1.10	3.83	1.64	1.10	1.64	1.10	0.55	0.55
Sebocyte, donor2	11301-117B5	18.38	12.87	1.84	1.84	1.38	0.00	0.46	0.00	0.46	0.00
Sebocyte, donor3	11378-118B1	21.85	10.31	3.71	2.06	1.44	0.00	0.41	0.62	0.62	0.41
Sertoli Cells, donor1	11255-116F4	53.01	28.16	23.19	0.00	6.63	3.31	0.00	1.66	3.31	1.66
Sertoli Cells, donor2	11333-117F1	36.72	14.12	16.95	2.82	2.82	2.82	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	25.25	11.26	12.58	5.01	2.64	1.67	1.58	1.76	0.44	0.26
Skeletal Muscle Cells, donor2	11358-117H8	5.78	2.89	7.95	1.45	0.72	0.72	0.00	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	30.10	14.21	9.20	1.67	0.84	0.00	0.84	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	22.46	13.82	19.32	3.30	1.57	1.26	2.04	0.79	0.79	0.63
Skeletal Muscle Cells, donor5	11455-119A6	21.85	13.08	17.39	3.42	2.97	2.23	1.49	0.59	0.89	0.45
Skeletal Muscle Cells, donor6	11459-119B1	26.47	17.54	20.01	4.00	2.62	1.23	2.62	0.62	0.62	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	33.14	17.01	12.98	4.16	2.02	1.51	0.88	1.89	1.39	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	30.68	15.55	16.27	3.14	2.43	0.86	1.71	1.28	0.86	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	30.46	18.65	25.40	3.47	4.07	2.28	2.18	1.69	1.19	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	19.55	9.86	14.32	2.11	0.67	1.10	1.01	1.43	0.42	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	10.86	5.79	0.72	2.90	0.72	0.00	2.17	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.25	8.53	8.53	1.10	0.28	0.55	0.55	0.41	0.69	0.41
Skin - palm, donor1	10286-104F7	85.96	80.58	8.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	21.77	11.53	5.62	3.60	1.30	1.30	1.30	0.72	0.43	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	72.79	62.16	9.81	7.36	2.45	4.09	3.27	0.82	0.82	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	19.73	10.65	6.75	3.76	0.65	1.56	1.17	0.78	0.52	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	31.42	14.73	5.56	3.20	2.78	0.56	0.97	1.25	1.11	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	28.83	15.89	9.56	4.08	2.39	1.13	0.70	2.25	0.70	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	98.96	58.36	17.13	15.65	3.17	4.44	1.48	2.75	0.85	3.81
Small Airway Epithelial Cells, donor3	11406-118E2	39.35	24.66	11.77	3.60	5.25	1.27	1.20	1.87	0.82	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.45	17.59	6.17	3.70	4.01	0.62	1.54	0.62	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	34.24	11.78	5.78	2.89	2.45	0.44	1.11	0.44	0.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.99	11.76	6.47	4.11	2.94	0.59	1.76	1.18	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	8.84	6.41	3.98	1.77	2.43	0.88	0.44	0.44	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.60	3.15	6.30	0.79	1.97	0.79	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.86	10.04	10.82	0.77	2.32	0.00	0.00	1.55	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	42.03	9.01	18.01	7.01	2.00	4.00	0.00	1.00	3.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	11.18	5.19	2.26	1.73	0.93	0.53	0.80	0.27	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	31.47	10.86	11.97	3.10	2.22	1.55	1.55	1.55	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	23.81	10.63	6.91	1.79	2.05	0.77	1.92	0.90	0.77	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	21.49	10.42	5.54	2.60	1.30	0.00	0.65	0.98	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.36	8.56	7.97	3.54	2.95	1.18	1.18	1.48	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	31.18	13.24	8.68	4.41	1.99	0.57	1.00	0.71	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	10.09	4.07	7.81	1.79	1.95	0.65	0.49	0.49	0.33	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	27.40	19.48	9.44	3.04	1.52	0.00	0.00	2.13	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	26.77	10.36	8.84	2.78	1.52	0.51	1.52	1.77	1.01	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.87	3.81	4.29	0.95	0.00	0.95	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	24.92	14.16	10.03	3.24	1.62	0.29	1.03	0.88	0.29	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.42	14.21	9.69	3.66	1.94	0.22	0.86	1.51	0.86	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	29.18	14.48	9.87	3.78	3.88	0.84	1.36	1.89	0.52	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.52	3.40	6.03	2.32	1.08	1.08	1.39	0.93	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	4.31	4.31	1.08	0.00	1.08	2.16	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.54	5.68	5.38	4.48	1.49	1.49	1.20	0.90	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.53	4.78	4.44	2.05	1.37	0.00	0.00	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	39.58	20.97	7.93	3.69	3.69	1.10	1.57	1.81	0.47	1.02
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	52.43	17.31	22.04	2.92	3.72	1.61	2.72	1.61	1.51	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	19.80	10.01	10.01	3.41	1.82	1.14	1.37	1.82	0.91	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	5.43	2.42	6.04	3.62	0.60	0.60	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	35.50	14.57	18.81	5.30	5.03	0.53	1.59	1.85	0.79	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	38.48	17.44	7.86	5.73	2.80	0.67	1.73	1.07	0.40	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	41.20	14.78	12.65	3.51	1.50	2.00	1.88	1.63	0.88	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.79	9.39	9.39	2.03	1.27	1.01	0.51	0.76	0.76	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	21.86	12.21	15.08	3.17	2.86	1.81	2.56	0.90	1.51	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	17.25	13.50	6.75	2.25	0.75	0.75	0.75	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	0.00	6.46	0.00	0.00	0.00	1.29	1.29	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.49	7.91	10.70	6.05	1.86	1.86	1.40	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	5.05	5.55	2.02	2.02	2.02	1.01	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.60	5.01	5.95	1.25	0.94	1.25	0.00	0.63	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.37	5.90	7.67	2.06	1.18	0.88	0.29	0.59	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	29.41	17.74	15.50	4.75	3.75	2.00	2.75	1.67	1.50	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	16.82	11.68	7.94	5.14	2.34	2.34	0.93	0.47	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.79	5.18	4.46	2.45	0.72	0.14	0.43	0.29	0.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.73	6.63	2.29	2.04	1.02	0.51	0.51	0.00	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	10.72	6.02	3.20	0.94	0.56	0.94	0.94	0.38	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	28.37	19.42	9.36	4.19	1.96	0.28	0.42	1.26	0.28	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	25.56	16.17	10.89	3.69	2.01	0.75	0.75	1.01	0.42	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	5.71	1.90	1.43	1.43	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.28	4.16	2.69	1.22	1.71	1.47	1.22	0.24	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	47.72	15.02	34.25	3.76	2.21	1.99	3.31	1.10	0.88	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	8.48	9.36	6.73	1.76	2.05	0.59	0.59	0.00	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	36.73	23.32	7.77	4.47	2.33	1.17	1.17	1.75	0.19	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	24.33	12.69	2.64	3.44	1.32	0.26	0.79	0.53	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	40.54	24.92	2.60	2.23	0.37	0.37	0.74	0.74	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	34.14	21.20	11.50	2.87	3.23	1.08	1.08	1.08	1.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	33.22	13.34	14.48	2.84	3.41	0.57	1.42	0.57	0.57	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	25.21	14.18	8.67	7.88	1.97	0.79	1.97	1.97	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	34.79	23.87	9.14	6.09	1.78	0.76	0.51	1.27	0.51	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	49.91	30.75	11.98	3.59	1.20	0.40	1.20	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	26.75	10.87	10.45	3.76	0.42	1.25	0.84	0.42	0.00	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	22.92	12.83	9.63	2.29	0.92	1.83	1.38	1.38	0.92	0.92
Synoviocyte, donor1	11291-117A4	49.99	17.84	21.21	2.86	3.37	1.68	2.02	1.01	0.67	0.34
Synoviocyte, donor2	11368-117I9	39.39	11.23	11.40	1.84	3.52	1.84	1.51	2.18	0.67	0.34
Synoviocyte, donor3	11440-118H9	34.85	15.86	6.26	2.68	4.24	3.13	1.34	1.34	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	16.44	9.65	7.50	3.93	3.22	1.43	0.36	1.07	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	11.89	3.96	0.00	0.00	0.00	1.98	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.36	8.57	6.71	2.08	2.32	0.93	0.93	0.93	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	18.35	12.11	2.87	3.08	1.58	0.65	0.36	0.86	0.29	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	10.82	8.50	4.64	0.77	0.77	0.39	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	17.75	4.01	3.44	1.72	1.15	1.15	0.57	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	47.36	24.24	11.93	4.06	3.94	1.11	2.09	0.86	0.12	1.11
Urethra, donor2	10319-105A4	172.65	131.29	17.98	5.40	3.60	5.40	1.80	5.40	0.00	3.60
Urothelial Cells, donor1	11520-119H8	15.41	6.91	4.52	1.06	1.33	0.53	1.06	0.00	0.80	0.00
Urothelial Cells, donor2	11600-120H7	14.42	6.41	3.61	2.80	1.20	0.80	0.40	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	14.21	7.79	4.58	1.38	0.46	0.92	0.69	0.23	0.00	0.23
Urothelial cells, donor0	11216-116B1	37.89	20.73	12.04	4.46	3.34	1.56	1.34	0.45	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	0.00	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	21.59	11.23	21.83	3.58	4.93	1.73	2.10	1.23	0.49	0.37
Wilms' tumor cell line:HFWT	10597-108E3	19.36	15.84	16.72	7.04	2.64	0.00	0.88	2.64	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	28.21	27.09	10.33	1.96	5.59	1.12	0.84	2.23	0.56	0.28
achilles tendon, donor2	10292-104G4	49.60	49.60	4.13	4.13	2.07	12.40	0.00	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.24	0.71	0.00	0.36	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2.72	5.71	0.00	0.00	0.27	0.00	0.27	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.39	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.00	1.39	0.46	0.46	0.00	0.00	0.46	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	0.00	0.92	0.00	0.92	0.00	0.00	0.31	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.43	0.00	0.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	0.30	0.30	0.00	0.30	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.48	0.24	0.24	0.24	0.24	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	0.00	0.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	23.31	14.13	3.53	3.53	2.35	0.47	1.88	0.00	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	40.95	26.68	16.60	3.72	2.64	5.58	2.79	1.09	2.17	0.47
adipose, donor1	10184-103D4	114.94	111.42	22.28	5.86	1.76	2.35	0.00	1.17	0.59	4.10
adipose, donor2	10185-103D5	27.17	18.25	35.28	0.00	4.46	2.03	2.84	0.00	0.41	2.84
adipose, donor3	10186-103D6	36.21	27.50	31.31	0.82	4.08	1.91	1.09	1.36	1.36	3.81
adipose, donor4	10187-103D7	32.07	12.13	12.13	2.60	0.87	1.73	0.00	5.20	1.73	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	52.40	21.78	22.25	5.05	11.68	3.00	7.26	1.89	3.79	0.47
adrenal gland, adult, pool1	10081-102A9	14.55	21.83	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	99.69	52.52	14.29	5.36	3.93	7.50	2.50	2.50	2.86	1.43
amniotic membrane cells, donor1	12235-129G3	95.06	58.66	11.82	8.35	9.51	1.39	3.71	1.85	1.39	1.16
amniotic membrane cells, donor2	12236-129G4	48.01	31.11	22.31	5.75	4.40	1.35	2.70	2.03	1.01	0.34
amniotic membrane cells, donor3	12237-129G5	139.35	72.77	11.78	8.54	4.12	1.77	2.65	0.88	0.88	0.29
amygdala - adult, donor10196	10167-103B5	14.23	8.30	3.56	0.00	1.19	0.00	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	26.97	19.47	7.10	3.85	3.04	1.22	1.22	0.20	0.61	0.81
amygdala, newborn, donor10223	10360-105E9	10.33	11.62	3.55	1.61	0.65	0.32	0.97	1.61	0.32	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	31.45	25.59	12.35	5.73	6.24	1.02	1.02	2.42	0.38	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	80.50	35.41	71.48	4.01	5.34	3.34	1.34	4.34	0.00	2.67
aorta, adult, pool1	10052-101G7	155.93	94.14	31.58	6.86	12.36	8.63	8.04	2.55	2.16	0.78
appendix, adult	10189-103D9	21.73	18.24	11.26	4.66	1.94	2.33	2.72	0.39	1.16	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	51.63	20.38	9.51	2.72	2.72	2.72	2.72	1.36	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	18.83	13.62	29.26	6.81	6.95	1.74	1.74	2.61	0.43	0.29
b cell line:RPMI1788	10427-106D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	33.85	16.65	15.54	2.22	4.99	2.22	2.22	0.83	0.83	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	33.74	16.37	9.33	7.74	6.55	1.19	2.48	3.67	1.29	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	17.41	13.56	1.67	1.67	2.68	0.50	0.50	0.67	0.17	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	69.53	48.45	20.75	5.54	6.30	3.80	2.61	1.63	2.28	0.33
blood, adult, pool1	10053-101G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	9.42	4.28	3.43	3.43	1.71	1.71	0.00	1.71	0.86
bone marrow, adult	10192-103E3	47.24	20.24	14.85	0.67	1.35	4.72	2.70	0.00	1.35	0.00
brain, adult, donor1	10084-102B3	13.33	8.20	7.18	4.10	2.05	0.00	0.00	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	9.91	5.79	5.57	0.89	1.11	1.00	0.33	0.22	0.56	0.33
brain, fetal, pool1	10085-102B4	2.67	5.34	2.67	0.00	2.67	0.00	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	12.55	14.54	7.60	5.62	2.31	0.99	0.33	2.64	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	21.59	25.96	8.74	3.12	6.62	1.62	2.12	0.87	0.00	1.00
breast, adult, donor1	10080-102A8	42.93	39.14	9.47	1.89	3.16	3.79	4.42	3.16	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	13.08	22.74	11.69	5.21	3.81	2.29	3.43	1.65	0.89	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	16.08	17.93	8.66	5.26	7.73	1.24	1.24	1.86	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	35.22	28.09	4.37	3.91	0.23	1.38	1.61	0.69	0.92	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	16.22	16.70	7.26	1.69	2.91	1.21	0.48	0.24	0.24	1.21
carcinoid cell line:NCI-H1770	10703-109H1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	3.83	0.44	2.30	0.11	0.98	0.22	1.09	0.00	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	3.49	1.90	0.00	0.32	0.00	0.63	0.32	0.00	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	11.71	7.19	8.78	1.06	0.27	0.53	0.53	0.53	0.00	0.00
caudate nucleus - adult, donor10196	10177-103C6	25.33	21.88	8.06	4.61	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	20.25	14.06	8.70	3.85	2.51	0.50	0.84	0.50	0.67	0.67
caudate nucleus, adult, donor10258	10379-105H1	12.99	6.11	5.35	1.53	0.00	0.76	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	8.42	9.52	5.49	1.46	0.37	0.73	0.73	0.73	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	34.96	8.74	5.83	0.00	0.00	0.00	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	23.91	14.52	6.41	1.71	1.71	1.92	1.28	0.85	0.64	0.64
cerebellum, adult, pool1	10083-102B2	5.86	3.10	2.41	1.03	0.34	0.00	0.69	0.34	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	13.28	8.30	1.66	0.83	0.00	0.83	0.83	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	17.15	9.08	3.78	2.77	3.03	1.51	0.76	1.01	0.50	0.00
cerebrospinal fluid, donor2	10294-104G6	27.04	16.81	5.12	0.00	0.00	0.00	0.73	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	28.76	17.69	15.38	2.30	4.46	2.16	1.15	4.31	0.29	0.86
cervical cancer cell line:ME-180	10553-107I4	52.86	23.86	15.74	6.13	5.30	0.99	2.98	2.82	0.66	0.50
cervix, adult, pool1	10013-101C4	52.50	49.14	48.09	10.18	9.66	8.19	4.30	3.78	1.57	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	33.72	15.61	5.57	4.46	2.51	0.70	1.67	0.98	0.56	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	5.23	7.84	13.06	0.00	0.00	0.00	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	43.99	34.42	5.22	5.84	4.35	1.37	1.12	2.24	0.25	0.37
choriocarcinoma cell line:SCH	10785-110H2	140.59	41.28	27.85	5.67	18.48	1.11	4.44	4.81	0.86	5.30
choriocarcinoma cell line:T3M-3	10618-108G6	27.51	28.94	4.51	7.83	8.30	1.19	2.61	2.85	1.42	0.24
chorionic membrane cells, donor1	12238-129G6	90.32	40.17	17.10	6.27	5.13	1.99	2.56	1.14	1.14	0.00
chorionic membrane cells, donor2	12239-129G7	52.50	20.58	16.31	4.37	4.08	1.69	1.49	1.79	0.70	0.80
chorionic membrane cells, donor3	12240-129G8	170.34	56.05	12.09	3.85	8.79	6.04	2.20	2.75	1.65	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	18.29	13.71	7.09	5.26	7.54	1.14	3.20	0.23	0.23	0.69
clear cell carcinoma cell line:TEN	10636-108I6	16.66	12.15	9.20	1.74	2.78	1.04	1.04	1.04	0.69	2.08
colon carcinoma cell line:CACO-2	10513-107D9	35.14	29.47	24.34	6.41	9.88	2.93	3.48	4.94	0.73	1.83
colon carcinoma cell line:COLO-320	10420-106C6	17.48	14.44	10.64	2.28	5.70	0.76	1.52	0.38	0.00	1.14
colon, adult, donor1	10082-102B1	29.75	33.32	13.09	10.71	4.76	0.00	1.19	4.76	1.19	0.00
colon, adult, pool1	10014-101C5	39.13	29.85	13.63	4.94	4.47	2.70	2.70	1.06	1.29	0.35
colon, fetal, donor1	10070-101I7	46.35	35.23	13.60	4.33	4.33	1.85	1.24	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	1.27	2.97	1.27	0.42	0.00	0.85	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1.66	1.21	1.66	1.36	0.00	0.15	0.00	0.15	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	2.12	2.12	0.99	0.99	0.14	0.56	0.00	0.28	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	15.70	8.84	8.84	3.65	1.55	0.77	0.66	0.66	0.44	0.77
cruciate ligament, donor2	10295-104G7	76.18	48.63	10.54	0.81	0.81	5.67	2.43	0.81	0.00	3.24
diaphragm, fetal, donor1	10069-101I6	26.48	20.06	12.84	4.82	1.61	3.21	0.80	0.00	4.01	0.80
diencephalon, adult	10193-103E4	4.80	6.48	2.16	2.16	0.72	0.24	0.24	0.00	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	25.13	9.49	16.16	3.59	4.87	2.56	2.56	2.05	1.03	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	11.07	6.50	8.91	1.93	0.96	0.24	0.24	0.96	0.00	0.72
ductus deferens, adult	10196-103E7	73.26	48.84	14.95	7.97	3.49	11.96	9.47	1.99	2.49	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	36.01	14.40	4.32	1.44	1.44	0.00	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	23.54	29.43	14.71	4.41	4.41	3.68	1.47	2.94	0.74	1.47
dura mater, adult, donor1	10041-101F5	25.77	18.33	19.08	2.40	3.22	6.28	1.40	0.74	1.32	0.99
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	9.10	3.78	7.33	4.00	1.55	1.55	2.22	1.55	1.11	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	12.75	8.31	5.73	3.87	1.00	0.57	1.15	0.86	0.57	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	11.10	17.27	3.08	11.10	1.85	0.62	0.62	1.85	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	10.90	9.08	2.72	3.03	2.42	0.00	1.21	0.61	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	12.97	9.26	5.56	6.48	3.70	0.62	0.93	1.85	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	10.51	9.19	3.94	7.88	2.63	0.00	0.00	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	13.07	9.05	14.08	3.35	5.03	1.68	0.34	0.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	38.97	24.83	9.24	8.88	5.80	2.36	2.54	1.27	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	27.82	13.51	7.40	3.54	2.57	0.96	1.93	0.64	0.80	0.00
epidermoid carcinoma cell line:A431	10426-106D3	26.23	14.45	11.12	1.45	3.89	1.00	1.11	0.89	0.33	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	271.55	132.97	46.52	29.26	58.29	16.50	17.82	25.52	4.95	3.63
epididymis, adult	10197-103E8	54.84	33.91	28.88	7.95	4.40	6.07	3.56	1.05	1.47	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.76	16.68	11.18	2.66	2.84	1.42	1.60	0.89	0.53	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	23.20	11.40	3.54	3.54	1.18	2.75	0.00	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	15.33	17.17	6.95	7.86	8.39	0.92	3.41	3.54	1.44	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	27.95	21.85	9.74	10.63	13.48	1.28	3.94	5.81	1.67	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	16.58	16.58	6.50	9.75	9.63	1.57	2.46	3.70	1.23	0.67
esophagus, adult, pool1	10015-101C6	65.94	34.93	14.33	4.57	6.26	6.48	2.97	1.27	1.49	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	34.44	21.92	15.78	4.63	1.63	2.25	0.75	1.00	0.25	0.88
eye - muscle inferior rectus, donor1	10272-104E2	210.07	101.41	7.24	0.00	0.00	2.41	0.00	0.00	4.83	0.00
eye - muscle lateral, donor2	10298-104H1	107.31	27.35	12.63	6.31	6.31	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	102.69	46.13	16.37	5.95	5.95	4.46	0.00	5.95	1.49	0.00
eye - muscle superior, donor2	10297-104G9	77.96	45.86	14.90	5.73	3.44	0.00	1.15	1.15	1.15	3.44
eye - vitreous humor, donor1	10268-104D7	14.57	4.37	4.37	2.91	0.00	1.46	0.00	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	36.86	16.53	19.83	4.07	3.81	4.83	2.54	0.25	1.53	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	19.62	16.80	4.49	4.87	4.23	0.38	1.54	1.67	0.38	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	33.00	27.07	14.25	12.35	7.60	0.71	2.37	2.85	1.19	0.47
frontal lobe, adult, pool1	10040-101F4	8.91	5.44	5.07	1.22	0.94	1.13	0.47	0.19	0.28	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	76.56	38.73	10.81	8.11	6.61	5.10	3.30	2.10	1.50	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	54.13	31.64	13.35	1.46	3.11	2.38	1.19	0.27	0.55	0.37
gall bladder, adult	10198-103E9	60.60	31.87	21.00	9.42	6.52	6.52	1.21	2.41	2.66	0.72
gamma delta positive T cells, donor1	11937-126A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	41.61	17.32	26.19	4.22	5.07	3.80	1.69	2.11	0.63	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	37.22	18.69	55.58	6.56	15.90	3.77	11.31	3.12	6.23	2.46
gastric cancer cell line:GSS	10560-108A2	46.68	27.46	13.73	9.15	2.75	1.83	1.83	2.75	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	0.91	2.97	1.83	0.00	0.23	0.00	0.00	0.00	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	7.23	10.21	3.10	1.72	1.72	0.11	0.69	1.49	0.46	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	25.75	15.40	19.17	2.52	1.68	1.12	0.28	0.70	0.42	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	52.13	44.65	14.97	13.72	7.98	1.50	2.99	3.74	0.75	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	13.72	8.97	3.17	3.91	1.58	0.74	1.06	0.53	0.32	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	14.04	7.16	2.95	1.69	1.40	0.14	0.56	0.70	0.28	0.42
glioblastoma cell line:T98G	10485-107A8	24.61	11.81	16.11	2.21	2.54	2.65	2.21	0.66	0.22	0.99
glioma cell line:GI-1	10413-106B8	34.85	13.77	11.72	7.03	3.81	1.46	0.88	0.88	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	13.12	11.66	4.37	3.64	0.00	0.73	1.46	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	25.14	20.26	6.35	2.69	3.91	0.98	0.73	0.49	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	9.58	8.22	4.11	6.85	0.00	0.00	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	8.53	6.40	5.86	1.07	0.00	0.00	1.07	0.53	0.00	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	40.00	15.36	14.40	5.44	2.24	2.24	2.24	4.80	0.96	0.00
hIPS +CCl2, biol_rep1	14383-156B9	27.09	18.82	13.31	2.75	3.21	0.00	0.92	3.67	0.92	1.38
hIPS +CCl2, biol_rep2	14384-156C1	26.52	14.63	15.09	3.20	3.20	1.37	0.46	1.83	3.20	0.91
hIPS +CCl2, biol_rep3	14385-156C2	32.20	13.53	16.75	3.86	5.80	0.64	1.93	2.58	0.00	1.93
hIPS, biol_rep1	14380-156B6	10.06	8.62	8.62	1.44	0.00	0.00	1.44	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	16.46	13.03	10.29	6.17	3.43	0.69	0.00	0.69	0.00	0.69
hIPS, biol_rep3	14382-156B8	14.35	15.45	6.62	1.10	0.00	1.10	1.10	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.29	0.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	28.10	22.72	17.64	3.89	1.79	4.19	2.99	1.20	0.90	0.90
heart - pulmonic valve, adult	10206-103F8	76.35	46.28	21.18	9.67	4.18	6.54	4.45	2.88	1.57	0.78
heart - tricuspid valve, adult	10207-103F9	59.95	29.98	19.15	0.83	2.50	1.67	0.83	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	47.34	31.22	8.77	4.08	4.49	1.84	3.06	0.61	0.41	0.20
heart, adult, diseased, donor1	10051-101G6	22.14	17.03	4.68	2.98	1.70	0.00	1.70	0.85	0.43	0.00
heart, adult, pool1	10016-101C7	22.77	14.49	8.05	2.99	5.06	1.38	1.38	1.15	0.69	0.23
heart, fetal, pool1	10046-101G1	30.39	29.88	38.71	6.78	11.91	3.18	4.31	2.16	1.03	1.44
hepatic mesenchymal tumor cell line:LI90	10778-110G4	36.71	18.51	17.59	4.94	5.55	1.23	2.16	2.16	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	64.22	53.51	36.86	26.16	9.51	3.57	3.57	9.51	3.57	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	42.76	32.71	22.21	11.16	5.86	0.44	2.21	5.86	0.44	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	42.48	29.01	22.21	11.89	5.83	0.49	1.82	5.83	1.82	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	45.07	30.32	22.43	14.25	7.17	0.51	2.53	5.25	1.41	2.93
hepatoma cell line:Li-7	10484-107A7	22.69	8.23	7.01	3.56	1.78	0.33	1.33	3.23	0.56	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	19.87	12.30	1.89	4.73	0.95	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	33.47	23.27	9.18	3.47	2.65	2.45	1.22	0.61	0.41	1.63
hippocampus, adult, donor10258	10374-105G5	6.97	3.49	2.49	2.49	0.50	0.50	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	9.16	6.70	5.64	0.70	0.70	0.70	0.35	1.41	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	37.23	29.30	14.65	9.77	7.32	1.83	0.00	6.71	3.05	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	20.03	21.40	13.74	3.73	3.53	0.59	2.16	3.53	0.39	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	30.47	24.88	18.28	4.82	3.30	1.02	1.27	3.81	1.02	4.06
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	20.30	24.81	34.96	0.00	2.26	1.69	3.95	0.00	0.00	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	21.95	26.08	30.73	1.03	6.97	2.07	1.29	0.26	1.55	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	18.22	23.16	40.24	0.76	4.56	1.14	0.38	1.14	0.76	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	49.05	34.16	39.12	1.46	1.17	4.09	0.88	2.34	2.34	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	37.27	34.47	56.44	1.94	2.59	3.88	2.80	1.29	1.94	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	44.21	35.45	50.47	2.50	2.09	6.67	3.34	2.50	2.50	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	27.70	24.63	42.39	3.32	4.50	4.97	1.42	2.84	1.66	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	36.80	26.04	46.93	2.25	4.02	5.79	2.57	2.89	2.41	2.41
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	29.63	21.55	51.17	2.69	6.06	4.04	2.02	2.69	2.02	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	20.97	18.15	15.18	2.82	4.69	0.63	1.72	2.66	0.78	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	20.63	17.69	10.81	2.46	1.47	0.00	0.49	0.98	0.00	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	19.20	24.44	4.36	5.24	0.87	0.87	0.87	5.24	0.00	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	29.97	34.17	65.86	0.95	4.77	2.67	2.48	0.76	0.38	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.47	39.25	64.97	1.74	2.18	2.18	0.87	1.74	0.44	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	46.48	54.97	43.48	2.00	4.00	5.00	0.00	2.50	0.00	4.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	17.90	23.93	42.95	0.38	3.96	0.75	0.94	0.19	0.57	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	19.55	28.65	37.29	0.45	2.27	0.00	0.91	0.91	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	25.06	31.32	44.48	0.31	3.13	1.25	0.31	0.63	1.25	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.60	25.15	30.37	1.31	2.61	1.63	1.14	2.78	1.96	3.92
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	22.93	24.39	40.35	2.03	2.61	2.61	2.90	1.45	0.58	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	35.57	30.79	35.87	2.09	2.69	0.60	0.30	2.39	1.49	3.89
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	23.83	20.51	21.43	3.51	2.96	0.55	1.85	2.77	1.29	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	28.81	25.68	19.11	3.71	4.28	1.14	1.71	2.57	1.43	3.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	41.24	26.13	19.19	6.53	6.94	2.86	1.22	4.08	0.41	3.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.04	27.11	34.50	2.11	3.52	2.82	4.22	1.41	1.06	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	27.87	28.82	40.86	1.90	5.38	0.95	1.27	1.58	0.63	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	30.56	26.93	41.16	2.12	5.45	1.82	1.82	3.03	0.61	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	28.96	25.34	39.82	1.03	6.21	0.52	2.07	0.00	1.55	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	30.55	20.59	27.89	0.00	4.65	3.32	3.32	1.33	1.33	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	32.07	22.83	30.27	1.28	1.80	2.05	2.31	2.31	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	29.66	26.08	27.61	2.56	3.58	2.05	1.79	1.79	0.77	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	38.62	21.96	41.65	1.51	3.79	0.76	4.54	0.76	0.00	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	30.25	24.87	26.21	4.37	3.02	3.02	1.34	2.35	0.67	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	29.22	18.60	21.01	3.38	5.55	0.48	2.17	2.90	0.97	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	23.62	22.73	23.17	5.35	2.23	0.89	2.23	2.23	0.45	4.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	29.27	20.98	33.17	4.88	4.39	0.98	1.46	2.93	1.95	3.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	23.23	27.51	47.68	2.14	8.56	2.14	2.44	0.61	0.31	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	130.13	172.42	13.01	13.01	3.25	0.00	0.00	3.25	0.00	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	36.40	38.72	29.45	2.98	1.99	1.32	0.33	2.32	0.33	1.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	30.65	36.67	41.05	1.64	5.47	3.28	0.00	2.19	3.83	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	40.53	40.17	37.27	2.53	2.17	3.26	1.81	0.36	2.53	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	28.83	22.78	24.91	1.78	3.91	2.49	2.49	0.71	1.42	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	22.67	28.64	34.61	2.39	2.39	0.00	2.39	2.39	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	35.75	28.85	36.16	2.03	5.15	3.25	3.93	2.71	1.63	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	31.79	26.67	23.98	2.16	2.42	3.23	2.69	1.35	1.62	1.62
immature langerhans cells, donor1	11904-125F5	4.12	1.70	0.00	0.00	0.00	0.24	0.00	0.00	0.00	0.24
immature langerhans cells, donor2	11905-125F6	29.31	7.13	2.38	0.00	0.00	2.38	0.00	0.00	0.00	1.58
insula, adult, pool1	10039-101F3	9.56	6.15	4.83	1.99	0.66	0.85	0.66	0.19	0.57	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	19.18	14.31	6.83	5.20	1.95	1.63	0.98	0.98	0.65	0.00
kidney, adult, pool1	10017-101C8	28.14	19.93	10.61	4.11	2.60	2.50	1.80	1.30	1.50	0.90
kidney, fetal, pool1	10045-101F9	45.20	26.31	55.39	5.45	5.80	5.52	3.11	1.41	1.13	1.13
large cell lung carcinoma cell line:IA-LM	10509-107D5	64.05	33.09	42.32	10.37	9.09	3.27	3.12	3.83	2.56	1.42
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.85	8.16	3.04	1.66	1.52	0.55	0.41	0.55	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	31.56	18.53	19.08	5.32	11.74	0.55	2.75	7.16	1.10	0.00
left atrium, adult, donor1	10079-102A7	32.69	25.61	6.54	2.18	5.45	1.63	1.63	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	13.15	16.69	5.06	1.01	2.02	1.52	0.51	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	21.89	9.03	25.45	0.82	2.74	1.92	0.55	1.37	0.55	0.55
leiomyoma cell line:10964C	10569-108B2	25.87	7.18	10.06	1.44	0.36	1.08	1.44	1.44	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	22.83	7.07	15.22	1.09	1.63	0.54	0.54	1.09	1.63	0.00
leiomyoma cell line:15425	10571-108B4	24.28	9.96	12.38	2.19	0.97	0.97	2.43	0.49	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	14.64	12.55	4.18	3.14	0.00	1.05	0.00	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.00	0.00	0.00	0.00	0.12	0.00	0.00	0.12	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	35.93	14.84	5.78	5.31	2.19	0.62	0.78	2.34	0.00	0.62
liposarcoma cell line:SW 872	10726-110A6	28.75	16.57	17.18	5.97	7.80	1.58	2.07	1.83	0.24	0.61
liver, adult, pool1	10018-101C9	56.24	29.82	6.97	3.57	1.94	1.13	1.62	0.81	0.81	0.16
liver, fetal, pool1	10086-102B5	5.64	7.53	2.82	1.88	0.00	0.00	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	25.37	17.64	6.71	3.50	0.87	0.87	1.17	0.15	0.00	0.58
locus coeruleus, adult, donor10252	10165-103B3	21.78	14.76	5.54	2.95	2.21	0.74	0.18	0.74	0.37	0.18
locus coeruleus, adult, donor10258	10375-105G6	11.57	7.05	6.21	1.69	1.69	0.28	0.85	0.00	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	25.24	27.76	6.31	5.47	0.84	0.00	0.84	2.10	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	9.13	5.12	1.94	2.91	2.08	0.14	0.97	0.69	0.28	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	13.10	13.10	13.79	8.96	3.45	3.45	0.00	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	29.79	18.45	13.18	2.11	5.27	5.80	1.98	0.79	1.58	0.40
lung, adult, pool1	10019-101D1	59.18	35.91	17.36	4.73	5.32	3.43	2.95	0.71	0.95	0.71
lung, fetal, donor1	10068-101I5	209.20	81.63	70.21	14.84	9.70	7.14	6.28	1.43	1.71	4.85
lung, right lower lobe, adult, donor1	10075-102A3	44.45	35.28	14.66	5.04	4.12	3.21	3.21	1.83	1.83	1.83
lymph node, adult, donor1	10077-102A5	5.21	9.47	2.37	3.79	0.47	2.84	0.47	0.00	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	0.22	0.22	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	3.92	11.77	14.49	2.26	4.68	0.45	1.51	0.91	0.30	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	28.03	8.49	11.89	1.70	5.95	3.40	2.55	0.85	1.70	2.55
mature adipocyte, donor1	12231-129F8	145.63	33.30	16.87	10.66	10.21	14.21	17.32	2.22	10.66	0.89
mature adipocyte, donor2	12232-129F9	113.52	28.85	19.30	6.85	6.23	7.68	13.28	1.66	7.68	3.11
mature adipocyte, donor3	12233-129G1	103.12	27.74	22.05	4.74	6.16	9.25	11.62	1.19	8.06	3.56
mature adipocyte, donor4	12234-129G2	81.33	23.69	16.32	5.00	5.26	10.79	6.58	1.84	3.16	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	21.68	17.39	11.67	5.48	4.53	1.43	2.38	1.43	1.43	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	6.77	10.15	2.26	2.26	0.00	0.00	0.00	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	23.54	16.55	6.25	2.39	2.21	0.55	0.92	0.18	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	6.35	3.49	2.86	4.45	0.64	1.59	0.32	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	16.63	10.66	0.85	1.28	0.85	0.00	0.00	0.85	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	12.83	9.96	2.70	2.53	0.68	0.51	0.51	0.34	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	20.37	15.28	6.15	2.76	1.70	1.91	1.70	0.21	0.21	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	3.85	5.78	5.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	28.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	8.26	8.97	2.15	0.72	0.00	0.36	0.00	0.36	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	49.32	21.42	11.68	5.19	1.95	0.65	0.65	1.30	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	32.82	23.07	11.46	6.04	4.18	1.70	1.70	0.93	0.46	0.62
medulla oblongata, adult, pool1	10038-101F2	17.55	10.61	9.31	4.33	1.71	1.31	1.55	0.65	0.41	0.33
medulla oblongata, newborn, donor10223	10361-105F1	22.22	22.22	11.80	5.55	0.69	1.04	1.04	0.69	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	27.23	18.16	20.81	1.33	2.21	3.10	3.32	2.21	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	4.40	2.57	1.22	0.98	1.35	0.24	0.49	0.37	0.37	0.00
melanoma cell line:COLO 679	10514-107E1	15.96	7.04	8.77	4.60	3.16	3.74	1.15	1.15	0.86	0.43
melanoma cell line:G-361	10465-106H6	12.22	6.79	6.79	0.54	1.09	1.63	0.54	0.00	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	18.09	13.03	7.24	1.81	1.81	0.54	1.27	0.54	0.90	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	31.91	17.18	9.97	3.07	0.46	0.77	0.77	0.77	0.61	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	27.27	10.54	7.45	2.73	2.00	1.45	0.73	1.27	0.55	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.50	12.84	3.73	2.90	0.00	2.07	1.24	0.00	2.07	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.04	17.98	7.87	4.35	2.39	0.42	1.26	2.11	0.84	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	31.39	12.32	10.98	4.04	2.50	1.54	1.16	1.93	0.77	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	31.93	13.19	18.05	2.78	1.39	1.39	6.25	1.39	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	22.48	11.16	6.18	5.15	4.12	0.51	1.72	1.03	0.51	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	34.04	12.65	10.01	2.99	1.15	1.27	1.50	1.50	0.35	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	25.47	13.66	11.41	4.11	1.46	0.93	1.46	1.06	0.27	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	26.06	12.83	7.43	4.05	2.30	1.76	0.95	0.81	0.41	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	31.44	20.34	9.96	8.25	2.99	1.28	0.71	1.42	0.57	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	17.13	17.46	5.93	5.27	2.31	0.66	0.66	0.66	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	30.30	17.43	16.05	5.40	2.35	1.52	0.97	0.83	0.55	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.85	13.61	14.31	4.54	2.44	2.09	1.05	1.05	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	29.40	16.74	11.64	3.47	3.27	1.63	1.02	0.20	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.18	12.58	15.10	2.16	2.88	0.00	1.08	0.36	1.08	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	31.24	13.86	9.62	3.21	1.97	1.24	1.45	0.31	0.31	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.70	10.03	16.64	2.96	1.82	0.46	0.68	1.14	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	45.73	17.20	7.97	3.36	2.10	0.42	0.42	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	37.36	18.83	7.92	5.68	2.39	0.75	0.60	1.05	0.75	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.56	14.18	8.40	7.00	2.80	1.05	0.70	1.84	0.35	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	36.82	18.78	18.78	7.36	3.31	0.37	3.31	1.84	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.46	12.02	23.75	4.01	3.15	1.43	2.86	0.00	1.43	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	19.37	10.95	7.16	3.37	2.11	1.26	0.00	1.68	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	24.20	12.79	9.59	4.11	1.37	5.02	1.37	0.46	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.07	13.05	10.49	3.07	1.28	2.81	1.02	1.02	1.02	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.10	12.56	12.04	3.66	2.62	1.57	1.83	0.79	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	24.34	18.18	6.47	3.39	1.85	3.08	0.62	0.62	0.92	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	24.01	10.59	7.77	2.59	1.18	1.41	0.94	0.24	0.71	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	21.32	13.20	8.80	5.75	1.69	3.72	2.37	1.02	1.02	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	22.79	11.00	7.07	3.14	1.96	1.18	2.75	1.96	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	24.56	12.97	7.88	3.24	1.39	0.46	1.85	1.39	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	22.21	19.04	7.50	4.33	2.02	1.15	1.73	2.31	2.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	21.19	14.95	9.59	4.46	2.23	2.23	1.12	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	23.07	13.94	9.85	4.57	1.44	1.44	1.92	1.44	1.44	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	23.47	7.33	10.27	6.60	4.40	2.93	2.93	0.73	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	23.83	13.09	7.05	4.03	1.68	2.01	1.68	1.68	1.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	22.52	11.46	10.23	6.14	0.41	0.41	2.05	2.05	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.61	11.60	1.29	3.01	2.58	2.15	0.86	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	8.20	5.47	5.47	2.73	5.47	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	10.33	0.00	5.16	5.16	0.00	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	20.14	10.07	9.74	2.60	1.62	1.30	2.27	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	7.27	10.18	4.36	1.45	1.45	2.91	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.66	5.33	5.33	4.26	0.53	2.67	1.07	1.60	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.90	5.72	7.36	2.45	0.00	0.82	1.64	1.64	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	14.38	7.77	10.11	5.44	1.17	1.17	1.17	1.17	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	14.69	6.30	6.30	0.00	0.00	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	9.93	7.95	5.96	0.99	0.00	0.99	0.99	1.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	14.30	9.53	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	17.20	8.89	5.34	2.37	1.19	1.78	1.78	0.59	1.19	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	15.84	9.75	8.53	3.66	1.22	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	5.07	4.43	1.90	0.63	1.90	1.27	1.90	0.00	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.31	6.90	4.14	1.72	1.03	0.34	0.69	0.69	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	6.45	4.30	2.15	0.00	0.00	2.15	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	3.44	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.93	5.70	1.63	4.07	0.00	1.63	0.41	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	3.18	1.59	4.77	2.38	0.79	0.79	1.59	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	13.56	2.36	2.36	2.36	1.18	1.18	0.59	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.04	5.92	3.12	2.81	0.62	0.94	0.31	1.56	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	13.37	1.34	6.68	0.00	4.01	1.34	2.67	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	3.55	14.19	3.55	0.00	5.91	2.37	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	5.14	17.98	0.00	0.00	2.57	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	14.46	10.33	11.01	4.13	2.07	3.44	0.69	3.44	0.00	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.35	7.42	7.42	1.48	2.47	1.48	0.49	1.48	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	3.36	5.61	3.36	1.12	2.24	1.12	2.24	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	15.27	6.36	5.09	1.27	1.27	0.00	0.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.07	7.25	4.84	0.40	1.61	0.81	0.40	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	6.54	2.18	0.00	2.18	0.00	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	5.07	5.07	1.27	0.00	0.00	1.27	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.35	9.10	4.25	1.21	1.82	0.61	0.61	1.21	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	18.08	4.52	9.04	0.00	4.52	0.00	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	16.47	8.24	7.41	0.82	4.12	0.00	0.00	2.47	0.82	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	12.30	9.52	8.33	3.37	0.79	2.78	1.39	0.79	0.79	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.30	5.52	4.87	0.97	0.97	2.27	1.30	1.30	1.62	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	16.30	3.06	10.19	2.04	1.02	3.06	3.06	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.85	17.02	10.06	3.09	0.77	0.77	1.55	0.00	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	15.59	12.76	5.20	1.65	5.67	0.47	1.65	0.24	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	39.62	15.75	32.90	4.63	3.01	3.71	1.85	1.39	0.70	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	4.27	0.00	0.00	0.00	8.55	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.28	4.42	1.64	0.92	0.31	0.31	0.31	0.41	0.10	0.21
mesothelioma cell line:Mero-25	10850-111F4	21.56	10.44	11.35	2.27	2.04	2.72	2.04	1.36	1.13	0.45
mesothelioma cell line:Mero-41	10851-111F5	17.60	19.31	9.78	5.62	0.98	1.96	1.96	0.49	0.49	0.49
mesothelioma cell line:Mero-48a	10852-111F6	14.39	8.64	6.20	4.65	1.33	0.89	2.44	0.44	0.66	0.44
mesothelioma cell line:Mero-82	10853-111F7	27.33	14.19	11.83	2.89	3.42	2.10	1.58	2.37	1.58	0.79
mesothelioma cell line:Mero-83	10854-111F8	23.32	11.75	5.11	3.23	2.21	1.53	1.02	1.19	0.68	0.68
mesothelioma cell line:Mero-84	10855-111F9	17.69	8.59	8.09	2.27	2.78	0.25	2.53	1.26	0.25	0.76
mesothelioma cell line:Mero-95	10856-111G1	14.70	13.25	6.63	2.69	2.07	0.62	1.45	2.48	0.83	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	32.80	17.23	13.09	7.95	1.99	1.99	2.98	4.31	0.99	0.83
mesothelioma cell line:NCI-H226	10846-111E9	20.45	12.13	10.14	5.61	1.63	0.90	1.45	1.27	0.72	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	24.60	19.82	9.22	4.95	0.85	2.90	1.54	1.20	1.20	1.02
mesothelioma cell line:NCI-H28	10845-111E8	14.25	8.65	3.56	2.29	1.02	0.00	0.25	0.76	0.00	0.76
mesothelioma cell line:No36	10857-111G2	12.72	8.48	2.94	2.61	0.98	0.65	0.00	1.30	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	8.40	8.67	3.79	2.98	1.63	0.81	0.27	0.81	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	0.38	0.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	0.12	0.24	0.12	0.00	0.00	0.00	0.00	0.00	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	0.36	0.18	0.00	0.18	0.00	0.00	0.00	0.00	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	25.47	10.77	10.45	4.90	7.18	0.98	1.63	1.96	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	37.94	19.92	12.29	2.54	9.75	0.85	4.24	2.76	0.21	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	22.81	11.29	1.61	1.61	2.99	0.46	1.84	0.92	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1.85	1.11	0.00	0.37	0.18	0.00	0.00	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.86	13.19	6.59	8.12	4.57	0.51	2.03	5.07	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	34.13	28.83	2.35	9.22	3.73	1.96	1.18	0.59	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	38.44	19.95	6.57	1.45	3.79	0.56	1.45	0.22	0.33	0.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	34.12	19.56	4.41	2.28	4.19	0.44	1.40	0.59	0.15	0.29
nasal epithelial cells, donor2	12227-129F4	32.57	16.56	8.83	4.97	2.76	1.66	1.66	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	0.23	0.00	0.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	0.19	0.00	0.56	0.19	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	25.31	8.01	8.44	1.48	2.11	2.32	0.63	0.21	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	72.35	26.57	9.25	0.95	0.95	2.61	0.95	0.00	0.47	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	63.19	17.26	15.84	1.43	0.63	2.85	1.27	0.00	1.27	2.06
neuroectodermal tumor cell line:TASK1	10774-110F9	38.84	11.87	15.50	2.62	2.21	1.21	0.81	0.81	0.40	1.61
neuroepithelioma cell line:SK-N-MC	10728-110A8	20.98	7.63	0.64	1.27	0.00	0.64	0.00	0.64	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	23.42	13.31	8.52	5.06	5.32	0.27	3.99	0.53	0.53	0.00
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	35.91	16.03	16.67	0.96	3.53	1.28	0.32	0.64	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	22.86	11.04	12.88	1.84	1.05	0.79	0.26	1.31	0.26	0.53
nucleus accumbens, adult, pool1	10037-101F1	11.15	5.53	4.69	2.25	1.41	0.66	0.56	0.19	0.56	0.84
occipital cortex - adult, donor10196	10172-103C1	16.48	16.48	0.00	0.00	0.00	0.00	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	26.03	18.25	4.56	2.95	4.29	1.07	1.88	0.27	0.54	0.81
occipital cortex, newborn, donor10223	10355-105E4	6.91	4.37	2.18	0.36	0.73	0.36	0.36	0.73	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	5.51	5.51	2.89	0.79	0.79	0.26	0.79	0.00	0.52	0.52
occipital lobe, fetal, donor1	10073-102A1	4.72	6.01	4.29	0.43	0.86	0.00	0.00	0.43	0.43	0.00
occipital pole, adult, pool1	10036-101E9	6.62	2.29	4.49	1.02	1.18	0.79	0.63	0.24	0.39	0.16
olfactory region, adult	10195-103E6	8.60	8.22	3.44	1.72	1.53	0.96	1.15	0.38	0.19	0.76
optic nerve, donor1	10277-104E7	24.01	16.01	6.00	2.00	2.00	2.00	2.00	0.00	0.00	4.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	28.02	19.93	8.54	6.15	5.58	1.03	2.39	3.87	0.57	1.25
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	10.44	6.46	7.28	0.82	2.47	0.69	0.41	0.27	0.41	0.96
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.93	10.84	6.26	2.03	1.02	0.17	0.51	1.52	0.51	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	18.25	11.55	22.29	2.89	5.66	1.73	2.08	1.96	0.81	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	49.39	33.22	10.29	7.94	4.70	2.35	2.94	0.88	2.35	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	65.40	22.42	34.57	27.10	14.02	1.87	1.87	4.67	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	24.60	12.09	12.51	2.76	4.03	1.27	2.33	0.64	1.27	1.27
ovary, adult, pool1	10020-101D2	52.85	32.93	48.57	9.00	7.60	3.93	3.58	3.23	1.05	0.79
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	39.05	22.18	14.30	6.60	6.23	0.92	2.75	3.30	0.55	0.55
pancreas, adult, donor1	10049-101G4	10.35	11.29	1.88	0.00	0.94	0.94	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	41.37	36.06	5.03	6.99	9.22	4.75	1.96	1.12	1.12	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	27.26	16.18	8.35	13.97	4.26	4.77	1.53	2.04	1.36	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	53.48	37.92	16.39	8.44	8.11	1.99	2.32	2.32	0.83	0.83
paracentral gyrus, adult, pool1	10035-101E8	6.59	4.48	3.66	1.92	0.64	0.27	0.46	0.27	0.37	0.00
parietal cortex, adult, donor10258	10373-105G4	7.34	0.73	2.94	2.20	0.00	0.73	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	11.29	4.70	0.94	1.88	0.94	0.00	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	24.23	14.25	5.70	2.85	1.71	0.86	1.43	1.43	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	7.75	5.90	4.41	3.17	1.06	0.79	0.70	0.35	0.44	0.18
parietal lobe, fetal, donor1	10072-101I9	12.61	7.76	6.79	1.94	0.97	0.97	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	8.60	8.60	5.61	0.37	0.00	0.37	0.37	1.12	0.37	0.37
parotid gland, adult	10199-103F1	25.28	10.48	11.10	3.08	6.78	9.25	3.70	0.00	3.08	0.62
penis, adult	10200-103F2	59.62	30.62	28.47	4.30	5.37	5.37	4.30	2.15	2.69	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	36.63	5.02	15.62	0.56	0.74	1.12	0.56	0.56	0.56	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	198.44	104.03	163.76	43.56	55.80	20.11	19.67	13.40	6.26	4.37
pineal gland - adult, donor10196	10179-103C8	9.68	7.10	1.29	1.29	0.65	0.00	0.65	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	13.62	7.70	1.18	1.78	0.00	1.18	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	7.52	6.27	1.25	1.25	0.00	0.00	0.63	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	18.21	6.07	14.17	0.00	0.00	0.00	3.04	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	17.72	11.99	8.34	2.61	2.61	1.04	1.56	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	3.40	6.81	2.55	0.00	0.85	0.00	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	66.01	36.12	12.36	5.16	3.55	2.26	2.04	0.97	0.43	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	0.13	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.92	13.23	5.91	3.58	2.80	0.16	0.16	0.47	0.62	0.16
pons, adult, pool1	10033-101E6	6.20	4.48	3.10	1.29	0.34	0.60	0.26	0.00	0.17	0.34
postcentral gyrus, adult, pool1	10032-101E5	6.28	5.06	3.31	1.83	0.70	1.05	0.61	0.09	0.26	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	21.12	18.06	8.30	6.26	5.54	1.31	2.18	0.87	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	31.04	21.60	6.53	14.88	5.81	2.54	2.00	2.54	0.00	0.91
prostate, adult, pool1	10022-101D4	58.86	35.64	24.49	7.98	7.62	4.99	4.17	1.54	1.36	0.36
putamen, adult, donor10196	10176-103C5	15.11	9.68	4.49	1.42	1.18	0.47	0.71	0.24	0.00	0.24
putamen, adult, donor10252	10152-102I8	7.84	3.92	1.96	1.96	0.00	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	12.02	8.74	6.56	3.28	2.19	0.00	0.00	1.09	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	8.94	4.59	3.87	1.69	0.72	0.72	0.72	0.24	0.48	0.00
putamen, newborn, donor10223	10365-105F5	18.74	14.99	0.75	1.50	0.00	0.00	0.00	0.00	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	36.95	18.62	41.89	9.31	18.04	2.62	4.36	5.53	0.87	0.58
rectum, fetal, donor1	10067-101I4	58.42	47.29	51.47	6.95	8.35	1.39	0.00	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	13.57	15.48	3.60	2.12	1.70	0.64	0.21	0.00	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	24.02	38.52	2.49	0.00	4.56	0.00	1.24	0.00	0.41	0.41
retina, adult, pool1	10030-101E3	39.56	26.04	18.49	11.83	5.86	4.17	2.78	1.59	1.39	2.29
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	33.20	14.26	10.45	2.34	2.46	1.11	1.35	0.61	0.49	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	25.59	12.65	32.06	3.37	4.78	3.66	3.37	3.37	2.25	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	87.15	35.62	21.98	5.30	6.82	1.52	1.52	2.27	0.00	0.00
salivary acinar cells, donor1	11771-123I7	47.75	25.09	11.01	2.75	1.62	1.46	1.46	0.97	1.62	0.32
salivary acinar cells, donor2	11772-123I8	47.36	24.78	9.78	2.20	0.69	2.62	1.65	0.41	1.10	0.41
salivary acinar cells, donor3	11773-123I9	50.98	32.44	13.24	5.30	2.65	1.32	2.65	1.99	1.32	0.00
salivary gland, adult, pool1	10093-102C3	37.75	17.16	12.01	5.72	1.72	5.72	2.29	0.00	1.72	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	18.97	15.93	12.06	6.58	4.13	0.59	2.36	2.70	0.59	0.84
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	19.63	16.81	11.99	6.94	5.05	0.71	1.76	1.65	0.82	0.59
seminal vesicle, adult	10201-103F3	52.91	42.85	20.63	11.64	6.35	9.52	4.23	0.53	2.12	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.79	15.30	25.99	4.86	4.13	0.97	1.21	1.21	0.97	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.83	9.31	7.05	3.77	3.27	0.25	1.01	0.50	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	10.04	8.03	7.02	9.03	1.00	2.01	2.01	1.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	23.64	15.04	2.28	1.34	1.07	1.21	0.54	0.81	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	61.45	41.45	9.95	5.31	6.74	1.44	2.21	2.21	0.88	2.65
signet ring carcinoma cell line:NUGC-4	10483-107A6	13.55	7.48	4.52	2.19	1.16	2.84	1.42	0.39	0.39	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	31.92	30.50	1.42	2.84	1.42	1.42	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	57.33	24.23	14.27	2.40	5.04	3.00	2.52	1.44	1.20	0.60
skeletal muscle, fetal, donor1	10066-101I3	20.10	24.12	16.08	8.04	1.01	2.01	2.01	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	54.28	47.50	33.93	0.00	6.79	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	91.53	42.29	21.46	6.94	1.26	3.79	2.52	0.63	1.26	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	1.89	0.95	5.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	16.58	10.22	5.20	4.43	2.31	0.39	0.96	0.96	0.96	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	21.76	14.67	23.08	2.97	6.92	2.80	1.48	0.33	1.32	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.00	0.00	0.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	30.34	24.61	9.79	3.11	4.42	1.31	2.27	0.48	0.72	1.31
small intestine, fetal, donor1	10064-101I1	30.47	27.76	14.74	3.93	2.21	1.47	1.97	0.49	1.23	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	109.84	48.59	22.74	5.43	6.20	5.43	3.10	2.58	1.03	0.78
somatostatinoma cell line:QGP-1	10781-110G7	0.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	50.47	35.33	8.03	3.21	0.92	1.38	0.69	0.69	1.38	0.00
spinal cord, adult, donor10252	10159-103A6	38.24	20.11	7.10	2.76	1.18	0.79	0.79	1.18	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	22.14	15.22	1.38	10.38	0.69	0.69	1.38	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	31.10	13.42	21.95	7.32	1.22	2.44	1.22	2.44	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	30.77	24.80	6.89	5.97	2.30	0.46	2.30	1.84	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	43.31	15.08	18.37	6.42	4.03	3.14	3.73	2.84	1.64	0.15
spleen, adult, pool1	10025-101D7	7.16	9.25	7.27	4.19	0.66	1.65	0.55	0.11	0.55	0.00
spleen, fetal, pool1	10044-101F8	12.16	10.09	15.89	3.65	2.15	3.02	0.79	0.40	0.56	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.10	0.00	0.00	0.00	0.00	0.10	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.01	7.97	4.37	1.52	3.42	0.76	0.95	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	67.44	29.35	13.98	11.18	5.59	1.05	2.45	0.70	1.40	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	26.97	5.47	8.60	0.39	3.52	0.39	0.78	0.78	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	15.08	12.38	8.10	3.04	2.48	0.68	0.68	2.70	0.23	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.98	10.17	3.39	0.85	0.85	0.00	0.85	0.00	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	29.19	17.35	13.54	16.08	7.62	4.65	3.38	0.85	1.27	0.00
stomach, fetal, donor1	10062-101H8	34.18	37.38	35.24	2.14	4.27	4.27	3.20	0.00	2.14	4.27
submaxillary gland, adult	10202-103F4	27.34	14.24	8.55	4.56	5.13	5.70	2.28	0.00	1.14	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	20.15	14.33	7.27	2.28	2.28	1.66	0.83	0.00	0.00	0.21
substantia nigra, adult, donor10258	10371-105G2	18.10	9.31	5.17	4.66	1.55	0.52	0.00	0.52	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	10.60	5.65	4.95	5.65	0.71	1.41	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	38.06	14.67	8.94	5.04	2.29	1.83	2.52	0.23	1.83	0.23
temporal lobe, adult, pool1	10031-101E4	6.70	3.73	3.56	1.78	0.93	0.34	0.93	0.59	0.59	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	12.11	6.41	13.53	2.14	2.14	0.71	0.71	0.00	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.91	4.40	5.27	1.32	0.00	1.32	0.00	0.44	0.00	0.00
tenocyte, donor1	11763-123H8	37.35	17.11	12.92	2.44	2.79	2.44	1.75	2.09	1.05	0.70
tenocyte, donor2	11765-123I1	36.24	15.26	6.10	2.29	4.20	1.53	0.76	0.76	0.76	0.38
tenocyte, donor3	11768-123I4	25.21	12.60	8.53	3.71	1.48	3.34	0.74	1.85	0.00	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	24.13	9.35	5.78	1.02	2.72	1.02	1.02	0.85	0.51	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	17.26	8.94	32.37	1.54	6.01	0.31	0.31	1.08	0.46	0.31
teratocarcinoma cell line:PA-1	10807-111A6	58.27	24.18	42.62	3.41	6.66	1.86	2.01	3.56	0.62	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	33.13	14.60	11.68	4.82	8.89	3.43	3.55	1.65	1.14	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	11.35	10.21	12.48	3.03	3.40	1.51	1.89	1.51	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	23.01	10.91	14.18	3.16	8.51	0.33	3.60	6.22	1.31	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	7.49	6.84	2.61	2.61	1.30	0.98	0.98	0.65	0.00	0.33
testis, adult, pool1	10026-101D8	36.51	27.49	23.41	4.19	5.26	4.83	2.58	0.86	0.75	0.86
testis, adult, pool2	10096-102C6	33.38	23.91	13.98	6.32	1.80	0.90	0.00	0.45	0.45	3.61
thalamus - adult, donor10196	10168-103B6	32.02	24.29	5.52	2.21	0.00	0.00	2.21	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	22.66	16.88	7.50	3.28	1.41	1.25	0.94	0.00	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	3.08	3.08	6.16	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	9.72	6.09	4.61	2.31	0.66	1.15	0.00	0.16	0.16	0.99
thalamus, newborn, donor10223	10366-105F6	5.18	10.36	2.30	1.15	0.58	0.00	0.00	0.00	0.58	0.58
throat, adult	10209-103G2	40.45	18.97	10.49	4.74	3.50	5.24	3.50	1.00	2.50	0.25
throat, fetal, donor1	10061-101H7	46.32	25.60	26.81	4.88	3.96	7.62	3.35	1.83	1.52	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	28.22	12.32	10.14	1.99	1.79	2.98	1.59	0.40	1.39	0.79
thymus, adult, pool1	10027-101D9	4.87	2.78	2.78	0.89	0.30	0.70	0.30	0.10	0.20	0.00
thymus, fetal, pool1	10043-101F7	14.13	5.61	8.42	1.87	1.35	1.66	0.83	0.42	0.42	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	15.82	14.63	4.65	2.79	1.46	1.46	1.20	0.93	0.40	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	38.41	19.42	16.48	12.71	9.64	1.96	2.65	1.96	0.70	0.70
thyroid, adult, pool1	10028-101E1	55.15	34.53	41.34	3.92	9.80	5.41	4.57	1.68	1.68	1.12
thyroid, fetal, donor1	10060-101H6	58.01	35.07	23.47	5.54	4.48	3.95	1.85	1.85	2.37	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	141.66	46.19	3.08	0.00	0.00	6.16	3.08	0.00	6.16	0.00
tongue, adult	10203-103F5	38.61	23.72	14.65	5.58	1.86	4.42	2.09	1.63	0.70	0.00
tongue, fetal, donor1	10059-101H5	40.59	31.53	14.98	4.73	5.12	1.97	1.97	2.36	1.58	1.18
tonsil, adult, pool1	10047-101G2	27.95	16.73	9.32	2.20	2.10	3.41	0.80	0.40	0.90	0.50
trachea, adult, pool1	10029-101E2	39.75	23.48	12.60	4.25	3.68	4.58	2.45	0.98	1.15	0.98
trachea, fetal, donor1	10058-101H4	50.78	27.70	21.93	5.39	2.69	5.00	1.15	1.92	2.31	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	54.56	21.61	19.13	3.54	4.25	0.00	1.42	1.06	1.42	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	42.15	34.04	18.03	10.33	9.32	3.65	4.26	2.84	2.43	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	21.15	16.61	18.18	10.18	7.99	2.66	5.01	1.57	1.57	0.63
tridermal teratoma cell line:HGRT	10694-109G1	39.95	30.44	22.83	7.61	3.81	0.00	1.90	7.61	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	29.80	18.28	12.11	3.56	4.83	2.20	1.86	1.19	0.68	0.34
umbilical cord, fetal, donor1	10057-101H3	89.72	50.08	10.43	2.09	8.35	4.17	2.09	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	116.20	51.02	61.60	14.50	7.68	6.65	5.63	4.27	2.05	2.22
uterus, fetal, donor1	10055-101H1	71.67	41.98	50.68	3.07	8.19	4.10	2.56	1.02	1.02	0.51
vagina, adult	10204-103F6	60.10	40.71	12.28	10.34	9.05	7.11	6.46	0.65	1.94	0.00
vein, adult	10191-103E2	32.88	12.93	11.18	2.19	2.19	3.95	2.63	0.44	2.19	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00